Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

C3_BRONCHUS_LUNG_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C34 Hospital discharge: ICD-9 — 162 Hospital discharge: ICD-8 — 152 Cause of death: ICD-10 — C34 Cause of death: ICD-9 — 162 Cause of death: ICD-8 — 152 Cause of death: excluded ICD-9 — 1620 Cause of death: excluded ICD-8 — 1620 Cancer registry: Topography ICD-O-3 — C34 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	9966
4. Check minimum number of events None	9966
5. Include endpoints None	9966
6. Filter based on genotype QC (FinnGen only)	9966

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BRONCHUS_LUNG_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C34
HD_ICD_9	162
HD_ICD_8	152
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C34
COD_ICD_9	162
COD_ICD_8	152
COD_ICD_10_EXCL
COD_ICD_9_EXCL	1620
COD_ICD_8_EXCL	1620
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C34
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9966	2786	7180
Unadjusted period prevalence (%)	2.55	0.95	3.17
Median age at first event (years)	71.62	69.39	72.48

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5833: Matched controls
52309

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

323.0

335

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

323.0

422

A04AA55

ATC

palonosetron, combinations; systemic

+∞

323.0

373

Z51.5

ICD-10 Finland

Palliative care

25.3

323.0

1240

552

JN4BD

NOMESCO Finland

Extensive body CT

11.7

323.0

1360

1326

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

126.0

323.0

1966

210

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

24.9

323.0

848

354

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

317.9

323.0

766

WF004

NOMESCO Finland

Palliative radiotherapy

2228.6

323.0

691

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

2954.1

323.0

612

ZX090

NOMESCO Finland

Other technic of radiotherapy

468.8

323.0

346

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

22.5

323.0

3233

2738

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

323.0

743

A04AA01

ATC

ondansetron; systemic, rectal

36.6

323.0

1131

341

A03FA01

ATC

metoclopramide; systemic, rectal

13.5

323.0

2551

2854

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

323.0

402

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

323.0

416

GDC00

NOMESCO Finland

Lobectomy of lung

360.9

323.0

518

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

323.0

536

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

323.0

650

H02AB02

ATC

dexamethasone; systemic

141.9

323.0

2031

196

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

323.0

342

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

3066

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

9.8

323.0

1070

1173

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

545

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

323.0

693

UGC12

NOMESCO Finland

Flexible bronchoscopy

19.4

323.0

2582

2053

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.2

323.0

2451

9705

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

323.0

542

A04AA02

ATC

granisetron; systemic, transdermal

531.6

323.0

637

JN4AD

NOMESCO Finland

Body CT examination

9.9

323.0

798

826

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

323.0

522

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

350.1

323.0

504

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

323.0

366

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

323.0

709

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

323.0

1082

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

14490.5

323.0

1278

WF002

NOMESCO Finland

Radical radiotherapy

267.4

323.0

754

XX3DW

NOMESCO Finland

Time consuming IT work

9.9

323.0

1040

1119

N02AA05

ATC

oxycodone; systemic

7.8

323.0

2133

3583

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

323.0

442

L01CA04

ATC

vinorelbine; systemic

+∞

323.0

554

C61

ICD-10 Finland

Malignant neoplasm of prostate

141.6

323.0

384

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

3373.3

323.0

363

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

948.2

323.0

820

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

1823.5

323.0

841

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

6059.2

323.0

616

WF049

NOMESCO Finland

Radiotherapy of metastasis

3372.8

323.0

978

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

163.4

323.0

935

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

323.0

455

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

323.0

810

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

323.0

740

GD1AD

NOMESCO Finland

Thorax CT examination

9.4

323.0

787

855

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

323.0

568

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.3

323.0

1817

4090

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

323.0

388

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

323.0

519

WZC30

NOMESCO Finland

Teaching

4.9

314.4

1189

2603

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

306.6

304

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1435.0

296.0

298

R84

ICPC

Malignant neoplasm bronchus/lung

408.4

293.2

304

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

930.3

292.0

296

L03AA13

ATC

pegfilgrastim; parenteral

917.1

287.9

292

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

60.6

287.3

350

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2594.6

284.9

285

L01CB01

ATC

etoposide; systemic

+∞

276.1

274

R03BB04

ATC

tiotropium bromide; inhalant

3.8

275.6

1379

3898

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

25.8

275.4

403

150

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

10.0

267.5

576

568

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

265.9

3317

17383

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.0

265.8

2009

7737

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

632.8

263.8

270

A98

ICPC

Health maint/preventive medicine

0.3

259.2

3660

43353

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

252.7

251

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

248.7

247

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

245.6

244

WX302

NOMESCO Finland

Thoracal epidural anesthesy

10.9

239.9

491

437

116

Kela drug reimbursment

Prostate cancer

+∞

227.4

226

ZX070

NOMESCO Finland

Intensity modified radiotherapy

1071.9

227.1

230

TGD00

NOMESCO Finland

Needle biopsy of lung

76.6

221.5

261

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

221.3

220

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

220.3

219

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

179.6

213.1

231

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

212.2

211

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

205.1

204

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.8

200.5

992

2701

A04AD12

ATC

aprepitant; systemic

+∞

199.0

198

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

153.1

195.1

214

AA1BD

NOMESCO Finland

Extensive CT of head and brain

10.0

191.6

410

394

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

36.7

190.8

255

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

6.5

190.5

541

813

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

11.4

184.0

367

307

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

183.8

183

WF003

NOMESCO Finland

Adjuvant radiotherapy

227.1

183.5

196

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

47.8

178.3

226

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

835.9

177.7

181

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

176.8

176

ZX120

NOMESCO Finland

Intravenous

4.1

176.4

765

1839

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

167.4

166.1

181

H02AB06

ATC

prednisolone; systemic

2.2

165.6

3097

18026

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

392.6

164.3

171

115

Kela drug reimbursment

Breast cancer

+∞

163.6

163

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

11.2

161.6

324

273

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

156.1

1412

5729

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

+∞

154.5

154

B01AB05

ATC

enoxaparin; parenteral

2.3

154.5

2004

9789

A06AH03

ATC

naloxegol; oral

40.1

151.8

199

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

151.5

151

PJA12

NOMESCO Finland

Sentinel node biopsy

248.0

151.4

161

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

149.5

149

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

149.5

149

L03AA02

ATC

filgrastim; parenteral

58.3

149.5

183

191

Kela drug reimbursment

Erlotinib

+∞

148.5

148

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

+∞

147.5

147

JN4CD

NOMESCO Finland

Very extensive body CT

8.7

146.4

337

366

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.2

143.5

417

640

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

277.9

141.9

150

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

448.7

141.9

147

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

141.4

141

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

+∞

140.4

140

J01MA12

ATC

levofloxacin; systemic

2.5

140.3

1408

5996

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

+∞

138.4

138

ZX050

NOMESCO Finland

Stereotactic radiotherapy

85.6

136.1

158

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

41.6

135.4

176

L02AE02

ATC

leuprorelin; implant, parenteral

73.8

135.2

160

A79

ICPC

Malignancy NOS

135.1

132.7

147

L03AA14

ATC

lipegfilgrastim; parenteral

1236.1

132.3

134

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

12.1

131.5

253

195

D70.82

ICD-10 Finland

Drug-induced neutropenia

33.1

131.0

179

J01MA14

ATC

moxifloxacin; systemic

3.2

130.6

791

2459

B01AB10

ATC

tinzaparin; parenteral

4.7

130.4

490

1011

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

130.4

130

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

1214.7

130.3

132

N02AA01

ATC

morphine; systemic, rectal

14.3

129.5

231

150

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

+∞

128.3

128

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

404.7

127.9

133

C34.89

ICD-10 Finland

Malignant overall tumor of the bronchus and lung other or unspecified histology

+∞

127.3

127

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.7

125.3

607

1585

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1125.2

121.3

123

8000/3-C34.1

ICD-O-3

Neoplasm, malignant of upper lobe, lung

+∞

120.3

120

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

120.3

120

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

561.6

119.5

123

C34.15

ICD-10 Finland

Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma

+∞

118.3

118

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

117.7

665

1956

L01XE03

ATC

[U] erlotinib; oral

+∞

116.3

116

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

4.5

114.2

445

949

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

113.3

1539

7458

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

7.1

113.1

295

388

R04.2

ICD-10 Finland

Haemoptysis

4.4

113.1

444

954

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.2

111.6

376

687

N02AX02

ATC

tramadol; systemic, rectal

1.9

111.2

2632

15836

C34

ICD-10 Finland

Malignant neoplasm of bronchus and lung

+∞

109.2

109

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.5

108.3

571

1589

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

108.2

108

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.2

107.6

632

1908

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

110.7

107.3

121

C34.20

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung without histology

+∞

107.2

107

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

104.7

1360

6425

WW500

NOMESCO Finland

Blood transfusion

6.0

100.6

297

462

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

100.2

100

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.3

100.0

565

1653

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

103.3

99.5

113

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.6

98.4

806

3004

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

98.2

C34.21

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma

+∞

98.2

Z51.0

ICD-10 Finland

Radiotherapy session

901.6

97.2

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

97.2

C34.96

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma

+∞

97.2

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

97.2

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.9

97.0

291

462

R4110

NOMESCO Finland

Physiotherapy

2.0

96.2

1617

8452

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

35.5

95.5

128

J93.8

ICD-10 Finland

Other pneumothorax

24.2

94.7

140

XG410

NOMESCO Finland

Flow-volume spirometry

3.8

94.3

436

1085

1BA04

NOMESCO Finland

+∞

94.1

L02BG04

ATC

letrozole; oral

119.8

93.8

105

R03AC02

ATC

salbutamol; inhalant

1.8

93.7

2902

18707

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

33.2

93.3

127

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

37.5

92.8

123

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

96.8

92.7

106

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

91.1

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

34.6

89.7

121

C34.02

ICD-10 Finland

Malignant tumor of the main bronchial adenocarcinoma

+∞

88.1

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

86.1

C34.09

ICD-10 Finland

Malignant tumor of the main bronchus other or unspecified histology

+∞

86.1

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

85.3

795

3163

J94.8

ICD-10 Finland

Other specified pleural conditions

7.4

84.5

214

269

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

17.3

83.8

138

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

+∞

83.1

NK6AN

NOMESCO Finland

Total body bone isotope imaging

30.6

82.2

114

L02BB03

ATC

bicalutamide; oral

762.7

82.2

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

82.1

GDD00

NOMESCO Finland

Pneumonectomy

262.2

81.2

L01XE13

ATC

[U] afatinib; oral

+∞

81.1

TGA30

NOMESCO Finland

Thoracocentesis

11.4

80.0

157

126

N07BA03

ATC

varenicline; oral

4.1

79.1

333

760

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.2

79.0

448

1306

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

370.7

78.6

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

70.6

78.4

C34.35

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma

+∞

78.1

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

366.1

77.6

WX250

NOMESCO Finland

Intercostal blockade

69.9

77.4

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

76.1

C34.17

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary carcinoid

+∞

75.1

WX892

NOMESCO Finland

Monitored bed care

2.6

75.0

617

2285

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

47.5

74.5

GEA00

NOMESCO Finland

Mediastinoscopy

32.1

74.5

102

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.6

74.2

115

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

688.9

74.2

C34.37

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung carcinoid

+∞

74.1

C34.06

ICD-10 Finland

Malignant tumor of the main bronchial microcellular carcinoma

+∞

74.1

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

17.6

74.0

121

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

72.8

991

4685

N03AX16

ATC

pregabalin; oral

1.9

72.8

1399

7547

M05BX04

ATC

denosumab; parenteral

3.8

72.6

337

838

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

54.0

72.1

GDC10

NOMESCO Finland

Bilobectomy of lung

+∞

72.1

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.2

72.0

298

669

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

0.6

71.9

1386

18426

1CD01

NOMESCO Finland

+∞

70.0

HAC20

NOMESCO Finland

Total mastectomy

139.8

69.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

74.6

69.7

SAA01

NOMESCO Finland

Simple examination of mouth

0.6

69.1

2048

24654

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.5

68.4

720

11326

L01BC06

ATC

capecitabine; oral

+∞

68.0

3004

Kela drug reimbursment

Osimertinib

+∞

67.0

A02BC02

ATC

pantoprazole; systemic

1.6

66.8

3617

26183

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

66.3

461

1537

C50.99

ICD-10 Finland

Breast, unspecified

615.3

66.2

Y77

ICPC

Malignant neoplasm prostate

70.9

65.9

L02BA01

ATC

tamoxifen; oral

77.7

65.8

SAA02

NOMESCO Finland

Basic examination of mouth

0.6

65.5

1695

21147

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

161.0

65.1

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

65.0

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

110.4

64.9

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.0

64.3

187

285

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

158.7

64.2

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

64.0

8000/3-C34.3

ICD-O-3

Neoplasm, malignant of lower lobe, lung

+∞

64.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

48.4

63.7

341

Kela drug reimbursment

Afatinib and gefitinib

+∞

63.0

8140/3-C34.2

ICD-O-3

Adenocarcinoma, NOS, of middle lobe, lung

+∞

63.0

HA1AA

NOMESCO Finland

X-ray mammography

4.9

63.0

221

420

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.6

61.6

1034

14384

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.7

61.6

119

SFA10

NOMESCO Finland

Fillning on one surface of tooth

0.6

61.4

1357

17645

A06AD11

ATC

lactulose; oral

1.9

61.2

987

4951

1519

Kela drug reimbursment

+∞

60.0

JN6AD

NOMESCO Finland

CT of torso and neck

13.7

59.6

107

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

59.3

1155

6191

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

551.1

59.3

D38.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified

40.6

58.6

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

9.2

58.1

127

126

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

58.0

R03BB01

ATC

ipratropium bromide; inhalant

2.9

57.6

372

1183

WX402

NOMESCO Finland

General anaesthesia

2.1

56.7

722

3290

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

28.3

55.4

C34.29

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology

+∞

55.0

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.7

54.6

133

158

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

54.0

TGC00

NOMESCO Finland

Bronchial lavation

3.8

53.7

246

604

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

53.6

1196

6675

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

496.1

53.3

N05CF01

ATC

zopiclone; oral

1.6

53.2

1865

11829

8240/3-C34.9

ICD-O-3

Neuroendocrine tumor, NOS, of lung, NOS

+∞

53.0

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

53.0

PJD99

NOMESCO Finland

Excision of other lymph nodes

486.9

52.3

L01EB04

ATC

osimertinib; oral

+∞

52.0

R06.0

ICD-10 Finland

Dyspnoea

1.6

51.6

1550

9420

8551/3-C34.1

ICD-O-3

Acinar cell cystadenocarcinoma of upper lobe, lung

+∞

51.0

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.2

50.7

289

842

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

50.1

2429

16603

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

15.9

49.8

ZXC96

NOMESCO Finland

Robot assisted procedure

11.3

49.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

459.5

49.3

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.9

49.2

326

1051

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

73.8

48.5

N06DX01

ATC

memantine; oral

0.3

48.4

2715

WW200

SPAT

0.3

48.1

2767

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

48.0

8070/3-C34.0

ICD-O-3

Squamous cell carcinoma, NOS, of main bronchus

+∞

48.0

C34.13

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma

+∞

48.0

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

48.0

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

48.0

R85

ICPC

Malignant neopl respiratory other

64.6

47.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

47.4

903

4765

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.6

47.2

174

349

B01AB04

ATC

dalteparin; parenteral

2.7

47.2

342

1167

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

47.0

C34.85

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma

+∞

47.0

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

226.1

47.0

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.5

46.6

529

8271

8240/3-C34.3

ICD-O-3

Neuroendocrine tumor, NOS, of lower lobe, lung

+∞

46.0

5826

FHL

Lobectomy or bilobectomy

79.9

45.6

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.1

45.5

150

267

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.6

45.3

764

10774

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

216.8

45.0

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

44.8

607

2822

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

22.5

44.8

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.4

44.6

232

632

J93.9

ICD-10 Finland

Pneumothorax, unspecified

11.0

44.0

R50.9

ICD-10 Finland

Fever, unspecified

1.9

43.7

718

3593

P20

ICPC

Memory disturbance

0.5

43.4

319

5703

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

43.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.6

43.0

807

11111

WX600

NOMESCO Finland

Single shot through catheter

12.8

43.0

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

15.0

42.5

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

395.5

42.4

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

42.0

8041/3-C34.0

ICD-O-3

Small cell carcinoma, NOS, of main bronchus

+∞

42.0

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

42.0

K02.1

ICD-10 Finland

Caries of dentine

0.7

41.2

1531

18273

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

41.0

C34.26

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma

+∞

41.0

EB1AA

NOMESCO Finland

Tooth X-ray examination

0.7

40.7

1570

18623

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

11.0

40.6

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

0.6

40.3

1024

13207

SPAT1109

SPAT

Analgesia with portable analgesic pump

14.0

40.2

C10AA07

ATC

rosuvastatin; oral

0.6

40.2

710

9940

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

40.0

1623A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]

+∞

40.0

1BC05

NOMESCO Finland

+∞

40.0

L01XE02

ATC

[U] gefitinib; oral

+∞

40.0

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

14.1

39.8

R95

ICPC

Chron obstructive pulmonary disease

2.9

39.7

264

854

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.7

39.4

140

271

8250/3-C34.9

ICD-O-3

Lepidic adenocarcinoma of lung, NOS

+∞

39.0

1CD02

NOMESCO Finland

+∞

39.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

38.9

931

5247

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

24.1

38.3

J43.9

ICD-10 Finland

Emphysema, unspecified

3.9

38.2

167

395

C34.14

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma

+∞

38.0

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

38.0

WF099

NOMESCO Finland

Other radiotherapy

32.9

37.8

J86.9

ICD-10 Finland

Pyothorax without fistula

6.3

37.8

105

152

L15

ICPC

Knee symptom/complaint

0.5

37.6

456

7042

Z01.2

ICD-10 Finland

Dental examination

0.6

37.6

948

12283

C03CA01

ATC

furosemide; systemic

1.5

37.5

1980

13527

SPAT1053

SPAT

Memory test

0.6

37.4

499

7514

GDC20

NOMESCO Finland

Lobectomy of lung and sleeve resection of bronchus

+∞

37.0

C34.33

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma

+∞

37.0

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.8

36.6

108

169

A04AA03

ATC

tropisetron; systemic

340.7

36.4

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

36.3

752

4051

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.8

36.1

249

823

8070/3-C34.2

ICD-O-3

Squamous cell carcinoma, NOS, of middle lobe, lung

+∞

35.0

GD004

NOMESCO Finland

Palliative radiotherapy of trachea, bronchi and lungs

+∞

35.0

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

40.6

35.0

Z72.0

ICD-10 Finland

Tobacco use

3.6

34.8

165

419

GAA31

NOMESCO Finland

Thoracoscopy

14.3

34.4

D82

ICPC

Teeth/gum disease

0.6

34.2

713

9663

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

34.2

332

1328

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

72.3

34.1

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

4.4

34.1

130

271

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

34.1

919

5336

C50

ICD-10 Finland

Malignant neoplasm of breast

114.3

34.1

3001

Kela drug reimbursment

Alectinib

+∞

34.0

L01XX17

ATC

[U] topotecan; systemic

+∞

34.0

8046/3-C34.9

ICD-O-3

Non-small cell carcinoma of lung, NOS

+∞

34.0

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.4

33.8

137

3044

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.9

33.6

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.3

33.3

128

269

GCA32

NOMESCO Finland

Endoscopic insertion of stent into bronch

85.7

33.1

SDA01

NOMESCO Finland

Simple parodonthologic therapy

0.6

33.0

450

6762

1504

Kela drug reimbursment

Alectinib

+∞

33.0

C34.97

ICD-10 Finland

Malignant tumor in unspecified location in bronchial and pulmonary carcinoid

+∞

33.0

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

33.0

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

33.0

8480/3-C34.3

ICD-O-3

Mucinous adenocarcinoma of lower lobe, lung

+∞

33.0

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

32.7

2299

C10AA05

ATC

atorvastatin; oral

0.7

32.6

1615

18545

KMAK

NOMESCO Finland

0.7

32.6

1405

16523

R03DA04

ATC

theophylline; systemic, rectal

2.1

32.5

387

1697

SDA02

NOMESCO Finland

Parodonthologic therapy

0.6

32.4

743

9881

GCA05

NOMESCO Finland

Bronchoscopic laser therapy of lesion of bronchus

157.8

32.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

32.0

8551/3-C34.3

ICD-O-3

Acinar cell cystadenocarcinoma of lower lobe, lung

+∞

32.0

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

32.0

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

32.0

N06DA03

ATC

rivastigmine; oral, transdermal

0.2

31.3

1478

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

13.3

31.2

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

31.0

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

31.0

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

31.0

8240/3-C34.1

ICD-O-3

Neuroendocrine tumor, NOS, of upper lobe, lung

+∞

31.0

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

31.0

ZX112

NOMESCO Finland

Subcutaneous

6.7

30.9

109

D19

ICPC

Teeth/gum symptom/complaint

0.6

30.7

478

6953

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

286.0

30.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

30.3

1043

6425

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

19.3

30.2

C34.95

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma

+∞

30.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

30.0

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

30.0

GD2FN

NOMESCO Finland

Lung ventilation distribution isotope examination (radiospirometry)

+∞

30.0

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

30.0

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.5

29.8

245

899

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

281.6

29.5

B02AA02

ATC

tranexamic acid; systemic

1.8

29.4

533

2737

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.5

29.3

309

4982

XX1AD

NOMESCO Finland

Other CT-examination

99.2

29.3

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.2

29.2

159

450

N06DA02

ATC

donepezil; oral

0.4

29.2

2262

L01XE35

ATC

[U] osimertinib; oral

+∞

29.0

C34.34

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma

+∞

29.0

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

29.0

8046/3-C34.1

ICD-O-3

Non-small cell carcinoma of upper lobe, lung

+∞

29.0

G47.3

ICD-10 Finland

Sleep apnoea

0.6

28.9

534

7467

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.3

28.6

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.5

28.5

221

3908

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

28.4

468

6727

K03.64

ICD-10 Finland

Dental calculus supragingival

0.6

28.4

476

6815

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.7

28.1

1338

15570

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

28.0

L01ED03

ATC

alectinib; oral

+∞

28.0

169

Kela drug reimbursment

Crizotinib

+∞

28.0

GDC11

NOMESCO Finland

Thoracoscopic bilobectomy of lung

+∞

28.0

8041/3-C34.2

ICD-O-3

Small cell carcinoma, NOS, of middle lobe, lung

+∞

28.0

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

27.7

392

1844

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

262.8

27.5

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

262.8

27.5

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.7

27.4

123

299

GAC00

NOMESCO Finland

Biopsy of pleura

8.6

27.4

M01AH05

ATC

etoricoxib; oral

0.7

27.2

1892

20776

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.5

27.1

199

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

13.5

27.1

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.6

27.0

126

317

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

27.0

I10

ICD-10 Finland

Essential (primary) hypertension

0.7

26.9

2813

29134

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

5.3

26.8

143

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

5.9

26.8

118

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.6

26.8

644

8519

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.4

26.4

136

2766

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.9

26.2

166

C10AX09

ATC

ezetimibe; oral

0.5

26.1

264

4317

J01AA02

ATC

doxycycline; systemic

1.4

26.1

4095

33026

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

25.7

26.0

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

26.0

L01EB03

ATC

afatinib; oral

+∞

26.0

C34.27

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung carcinoid

+∞

26.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

25.9

492

2563

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

9.0

25.5

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

126.1

25.4

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.6

25.4

324

4972

H13

ICPC

Plugged feeling ear

0.6

25.3

528

7209

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.5

25.3

127

SPAT1312

SPAT

General health counselling

0.7

25.2

892

10968

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

25.1

941

11458

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

25.0

400

5805

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

25.0

8010/3-C34.3

ICD-O-3

Carcinoma, NOS, of lower lobe, lung

+∞

25.0

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

25.0

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

25.0

SPAT1310

SPAT

Counselling related to known health issue

0.7

24.9

976

11793

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

2.7

24.9

177

599

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

15.2

24.9

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.3

24.8

1802

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.9

24.7

105

244

L17

ICPC

Foot/toe symptom/complaint

0.7

24.6

725

9234

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

13.9

24.6

WX330

NOMESCO Finland

Paravertebral ansthesia

65.4

24.5

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

0.6

24.5

604

7969

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

36.0

24.4

SPAT1325

SPAT

Vaccination

0.7

24.4

1319

15122

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.3

24.0

1659

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

24.0

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

24.0

L01XE36

ATC

[U] alectinib; oral

+∞

24.0

L02BX02

ATC

degarelix; parenteral

+∞

24.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

11.2

23.9

B01AF01

ATC

rivaroxaban; oral

0.6

23.9

303

4662

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.7

23.8

1104

12980

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

63.1

23.6

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

81.1

23.5

WF090

NOMESCO Finland

Profylactic radiotherapy

117.0

23.5

G20

ICD-10 Finland

Parkinson disease

0.2

23.3

1203

R52.0

ICD-10 Finland

Acute pain

2.9

23.2

148

467

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

8.7

23.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

23.1

1501

10446

1623X

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]

+∞

23.0

GD002

NOMESCO Finland

Radical radiotherapy of trachea, bronchi and lungs

+∞

23.0

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

8.2

22.9

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

0.3

22.7

1347

RS221

NOMESCO Finland

3.9

22.7

219

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

22.6

923

11105

C90.0

ICD-10 Finland

Multiple myeloma

78.1

22.5

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

0.6

22.5

514

6894

A07AA02

ATC

nystatin; oral

1.9

22.4

328

1564

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.6

22.3

478

6503

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.7

22.3

1496

16660

1240

FHL

Bronchoscopy

3.9

22.2

223

L13

ICPC

Hip symptom/complaint

0.6

22.2

390

5543

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

24.0

22.2

N05BA04

ATC

oxazepam; oral

1.4

22.1

1169

7825

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

22.0

660

8399

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

22.0

GDB20

NOMESCO Finland

Segmental resection of lung

+∞

22.0

8246/3-C34.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of lung, NOS

+∞

22.0

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

22.0

8010/3-C34.1

ICD-O-3

Carcinoma, NOS, of upper lobe, lung

+∞

22.0

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

22.0

L01XE16

ATC

[U] crizotinib; oral

+∞

22.0

8250/3-C34.1

ICD-O-3

Lepidic adenocarcinoma of upper lobe, lung

+∞

22.0

1623C

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]

+∞

22.0

8250/3-C34.3

ICD-O-3

Lepidic adenocarcinoma of lower lobe, lung

+∞

22.0

R4190

NOMESCO Finland

Nutritional therapy

3.3

21.9

112

305

N05AD01

ATC

haloperidol; systemic

2.4

21.9

188

709

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

206.9

21.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

206.9

21.6

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

0.7

21.6

555

7273

J01FA06

ATC

roxithromycin; oral

1.3

21.5

1959

14358

XG460

NOMESCO Finland

Short time oxymetry

2.9

21.4

134

419

SPAT1043

SPAT

Audiometry

0.6

21.4

252

3959

M79.6

ICD-10 Finland

Pain in limb

0.7

21.3

1085

12616

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

21.2

282

1297

H02AB07

ATC

prednisone; oral

1.5

21.1

714

4353

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

21.0

325

Kela drug reimbursment

Erlotinib

+∞

21.0

WE198

NOMESCO Finland

Palliative cystotatic therapy

+∞

21.0

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

21.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

21.0

288

1338

M01AX05

ATC

glucosamine; oral

0.7

20.9

652

8239

PJA10

NOMESCO Finland

Exploration of lymph nodes

8.0

20.9

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

31.5

20.9

VALMI

NOMESCO Finland

0.6

20.8

476

6390

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

20.7

588

3432

128

Kela drug reimbursment

Cancers of female genital organs

197.9

20.7

5828

FHL

Pneumectomy

197.9

20.7

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

197.9

20.7

C09CA01

ATC

losartan; oral

0.7

20.7

809

9823

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

72.1

20.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

26.1

20.6

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

20.5

365

1864

GWE00

NOMESCO Finland

Reoperation for deep haemorrhage in thoracic surgery

28.0

20.3

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.9

20.1

124

C39.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the respiratory system

+∞

20.0

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

20.0

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

20.0

8140/3-C34.0

ICD-O-3

Adenocarcinoma, NOS, of main bronchus

+∞

20.0

SPAT1249

SPAT

Treatment-related counselling outside office

0.7

19.9

1323

14819

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

6.5

19.7

UGC02

NOMESCO Finland

Rigid bronchoscopy

13.1

19.7

GDC13

NOMESCO Finland

Extended lobectomy or bilobectomy of lung

188.9

19.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

99.0

19.6

ZYC01

SPAT

0.3

19.3

1199

OAB42

SPAT

0.3

19.3

1148

GDA10

NOMESCO Finland

Biopsy of lung

9.5

19.3

GDB10

NOMESCO Finland

Wedge resection of lung

20.1

19.1

I87.1

ICD-10 Finland

Compression of vein

20.1

19.1

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

29.2

19.1

N02AA03

ATC

hydromorphone; systemic, rectal

12.1

19.0

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.5

19.0

114

2201

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

19.0

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

+∞

19.0

1625A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]

+∞

19.0

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

19.0

N03AX14

ATC

levetiracetam; systemic

2.6

18.8

143

506

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

66.1

18.7

C32.1

ICD-10 Finland

Malignant neoplasm: Supraglottis

179.8

18.7

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.2

18.7

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.1

18.6

164

ZZR00

NOMESCO Finland

Flap of skin

5.1

18.5

104

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

5.9

18.5

H02

ICPC

Hearing complaint

0.6

18.2

340

4779

L03

ICPC

Low back symptom/complaint

0.7

18.0

589

7398

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.7

18.0

857

10113

C34.05

ICD-10 Finland

Malignant tumor of the main bronchial other non-microcellular carcinoma

+∞

18.0

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

18.0

9680/3-C34.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lung, NOS

+∞

18.0

C34.84

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary macrocellular anaplastic carcinoma

+∞

18.0

1623B

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]

+∞

18.0

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

18.0

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

18.0

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

18.0

C45.0

ICD-10 Finland

Mesothelioma of pleura

+∞

18.0

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

18.0

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

49.5

18.0

L08

ICPC

Shoulder symptom/complaint

0.7

18.0

491

6379

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.6

17.9

323

4579

D01BA02

ATC

terbinafine; oral; topical

0.7

17.9

776

9292

L02BG03

ATC

anastrozole; oral

63.1

17.8

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.3

17.7

1180

GCA02

NOMESCO Finland

Bronchoscopic electrocoagulation of lesion of bronchus

89.9

17.7

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

17.6

860

5648

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.8

17.6

R01AD12

ATC

fluticasone furoate; nasal

0.7

17.5

576

7231

F03

ICD-10 Finland

Unspecified dementia

0.4

17.3

1615

2391A

ICD-9 Finland

Neoplasm of unspecified nature, Respiratory system

9.9

17.3

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.5

17.2

217

Z00.0

ICD-10 Finland

General medical examination

0.7

17.2

474

6151

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

0.7

17.1

543

6864

SPAT1097

SPAT

Recording of ECG

0.7

17.1

470

6105

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

14.5

17.1

A02BA02

ATC

ranitidine; systemic

1.4

17.0

1063

7291

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

17.0

1625X

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]

+∞

17.0

C34.87

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary carcinoid

+∞

17.0

E34.0

ICD-10 Finland

Carcinoid syndrome

+∞

17.0

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

17.0

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

17.0

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

9.9

16.8

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

24.0

16.8

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

161.8

16.7

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.4

16.7

125

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.1

16.7

198

871

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

16.6

118

402

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

16.5

220

3355

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

16.5

394

2193

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.5

16.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

16.4

244

1171

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.5

16.4

124

2214

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.9

16.3

100

311

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

14.0

16.3

XX9XW

NOMESCO Finland

6.1

16.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

16.3

566

7045

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.6

16.2

256

3744

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

16.7

16.2

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

16.2

1016

11538

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

16.1

109

361

G04BD12

ATC

mirabegron; oral

0.6

16.0

233

3471

SPAT1301

SPAT

No procedures

0.8

16.0

1116

12494

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

16.0

9699/3-C34.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lung, NOS

+∞

16.0

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

16.0

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

+∞

16.0

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

16.0

8046/3-C34.3

ICD-O-3

Non-small cell carcinoma of lower lobe, lung

+∞

16.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

16.0

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

16.0

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

16.0

M25.5

ICD-10 Finland

Pain in joint

0.7

16.0

697

8356

JN4DD

NOMESCO Finland

Scout CT scan of torso

23.0

15.9

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

56.9

15.9

DAX08

NOMESCO Finland

Fitting of hearing aid

0.4

15.9

1550

ZX100

NOMESCO Finland

Oral

3.5

15.9

189

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

0.6

15.9

211

3217

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

80.9

15.8

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.6

15.8

219

3302

M05BA02

ATC

clodronic acid; systemic

31.5

15.8

KCC10

NOMESCO Finland

Cystoprostatectomy

152.8

15.8

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

152.8

15.8

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

152.8

15.8

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

15.7

191

848

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

0.8

15.7

1326

14489

J96.1

ICD-10 Finland

Chronic respiratory failure

2.2

15.6

169

713

P70

ICPC

Dementia

0.2

15.6

717

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.7

15.5

559

6920

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.7

15.5

107

357

A10BK03

ATC

empagliflozin; oral

0.5

15.3

126

2194

L90

ICPC

Osteoarthrosis of knee

0.5

15.3

105

1936

C09CA06

ATC

candesartan; oral

0.7

15.3

606

7383

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

0.3

15.3

1058

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

15.3

205

A02BC01

ATC

omeprazole; systemic

1.3

15.2

1441

10505

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

15.1

201

926

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

53.9

15.0

K80

ICPC

Cardiac arrhythmia NOS

0.5

15.0

133

2265

C39.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs

+∞

15.0

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

15.0

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

15.0

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

15.0

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

15.0

C38.3

ICD-10 Finland

Malignant neoplasm: Mediastinum, part unspecified

+∞

15.0

GD003

NOMESCO Finland

Adjuvant radiotherapy of trachea, bronchi and lungs

+∞

15.0

C38.4

ICD-10 Finland

Malignant neoplasm: Pleura

+∞

15.0

363

Kela drug reimbursment

Crizotinib

+∞

15.0

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

15.0

L01EB01

ATC

gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)

+∞

15.0

GA2CT

NOMESCO Finland

Pleural biopsy with CT guidance

+∞

15.0

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

15.0

C34.04

ICD-10 Finland

Malignant tumor of the main bronchial macrocellular anaplastic carcinoma

+∞

15.0

8020/3-C34.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of lung, NOS

+∞

15.0

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

15.0

320

1730

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

14.9

236

1159

UJC01

NOMESCO Finland

Scopy of lower throat

4.2

14.9

123

7866A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest

30.0

14.9

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

143.8

14.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

14.8

146

592

UGB02

NOMESCO Finland

Tracheoscopy

14.1

14.7

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

8.0

14.6

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.3

14.6

113

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

4.5

14.6

105

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.7

14.5

717

8448

SFA40

NOMESCO Finland

Replacement of krone of tooth

0.7

14.5

568

6935

SFA00

NOMESCO Finland

Small filling

0.6

14.4

227

3322

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

0.5

14.3

159

2544

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

13.2

14.3

HMAK

NOMESCO Finland

0.6

14.3

189

2887

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.4

14.3

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.3

14.1

1018

ZXA00

NOMESCO Finland

Right side

1.3

14.1

1373

10031

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

14.1

305

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.4

14.1

1543

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

6.6

14.1

J43.2

ICD-10 Finland

Centrilobular emphysema

6.1

14.0

R81

ICPC

Pneumonia

2.0

14.0

186

856

C76.1

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Thorax

+∞

14.0

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

14.0

8000/3-C34.0

ICD-O-3

Neoplasm, malignant of main bronchus

+∞

14.0

C32.9

ICD-10 Finland

Malignant neoplasm: Larynx, unspecified

+∞

14.0

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

14.0

8480/3-C34.1

ICD-O-3

Mucinous adenocarcinoma of upper lobe, lung

+∞

14.0

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

14.0

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

14.0

C34.25

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung other non-microcellular carcinoma

+∞

14.0

8240/3-C34.2

ICD-O-3

Neuroendocrine tumor, NOS, of middle lobe, lung

+∞

14.0

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

14.0

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

14.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

14.0

8480/3-C34.9

ICD-O-3

Mucinous adenocarcinoma of lung, NOS

+∞

14.0

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

+∞

14.0

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

14.0

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

14.0

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

14.0

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.1

13.9

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

72.0

13.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

13.9

1444

15431

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

134.8

13.8

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

134.8

13.8

TXQ05

NOMESCO Finland

Puncture of skin, site unspecified

134.8

13.8

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

32.4

13.7

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.1

13.6

227

H40.0

ICD-10 Finland

Glaucoma suspect

0.6

13.5

154

2441

N81.6

ICD-10 Finland

Rectocele

0.5

13.3

1515

R24

ICPC

Haemoptysis

3.9

13.3

124

B01AF02

ATC

apixaban; oral

0.6

13.3

288

3925

A10BK01

ATC

dapagliflozin; oral

0.4

13.3

1171

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

4.8

13.2

K86

ICPC

Hypertension uncomplicated

0.7

13.1

345

4531

OAB43

SPAT

0.4

13.1

1275

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

47.9

13.1

GD6AD

NOMESCO Finland

CT of chest and neck

12.9

13.1

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.6

13.1

193

2871

E83.50

ICD-10 Finland

Hypercalcemia

3.3

13.0

177

T90

ICPC

Diabetes non-insulin dependent

0.8

13.0

884

9975

Z01.1

ICD-10 Finland

Examination of ears and hearing

0.7

13.0

355

4624

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

13.0

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.0

8246/3-C34.1

ICD-O-3

Neuroendocrine carcinoma, NOS, of upper lobe, lung

+∞

13.0

8013/3-C34.9

ICD-O-3

Large cell neuroendocrine carcinoma of lung, NOS

+∞

13.0

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

13.0

8012/3-C34.1

ICD-O-3

Large cell carcinoma, NOS, of upper lobe, lung

+∞

13.0

L01CE01

ATC

topotecan; systemic

+∞

13.0

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

13.0

L01AX03

ATC

temozolomide; systemic

+∞

13.0

8249/3-C34.3

ICD-O-3

Neuroendocrine tumor, grade 2 of lower lobe, lung

+∞

13.0

8013/3-C34.1

ICD-O-3

Large cell neuroendocrine carcinoma of upper lobe, lung

+∞

13.0

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

13.0

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

13.0

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

13.0

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

13.0

C34.83

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary bronchoalveolar carcinoma

+∞

13.0

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

13.0

N07BC02

ATC

methadone; systemic

9.7

12.9

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

67.5

12.9

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

0.6

12.9

204

2984

-1

NOMESCO Finland

0.8

12.9

811

9250

R02

ICPC

Shortness of breath/dyspnoea

1.4

12.9

613

3995

A06AC01

ATC

ispaghula (psylla seeds); oral

0.7

12.9

739

8532

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

12.8

836

5747

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

125.8

12.8

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

125.8

12.8

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

0.5

12.7

1618

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

2.9

12.7

250

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

12.7

369

4751

DQA10

NOMESCO Finland

Biopsy of larynx

5.7

12.6

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

8.1

12.6

DFF00

NOMESCO Finland

Pure tone audiometry

0.6

12.6

204

2965

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.4

12.6

158

SGA01

NOMESCO Finland

Tooth opening as first aid

0.6

12.6

224

3185

J94.9

ICD-10 Finland

Pleural condition, unspecified

4.6

12.5

G04CB02

ATC

dutasteride; oral

0.6

12.5

207

2994

L02AE04

ATC

triptorelin; parenteral

35.9

12.5

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

35.9

12.5

X76

ICPC

Malignant neoplasm breast female

35.9

12.5

207

Kela drug reimbursment

Chronic arrhythmias

0.7

12.4

563

6731

M16.1

ICD-10 Finland

Other primary coxarthrosis

0.7

12.4

341

4440

M54.5

ICD-10 Finland

Low back pain

0.8

12.4

924

10303

R03AC13

ATC

formoterol; inhalant

1.7

12.3

250

1331

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.6

12.2

305

N04BD01

ATC

selegiline; oral

0.1

12.2

423

S02.51

ICD-10 Finland

Fracture of tooth, open

0.6

12.2

157

2411

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

2.0

12.1

153

693

1XC18

NOMESCO Finland

+∞

12.0

8249/3-C34.1

ICD-O-3

Neuroendocrine tumor, grade 2 of upper lobe, lung

+∞

12.0

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

12.0

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

12.0

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.0

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

12.0

8550/3-C34.1

ICD-O-3

Acinar cell carcinoma of upper lobe, lung

+∞

12.0

L02BG06

ATC

exemestane; oral

+∞

12.0

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

12.0

C34.93

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary bronchoalveolar carcinoma

+∞

12.0

5BX04

NOMESCO Finland

+∞

12.0

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

+∞

12.0

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

12.0

S77

ICPC

Malignant neoplasm of skin

9.0

12.0

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

6.1

11.9

HAE99

NOMESCO Finland

Other reconstruction of breast

28.8

11.9

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.5

11.9

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

116.8

11.9

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

11.9

254

3475

N87

ICPC

Parkinsonism

0.1

11.9

416

KAC10

NOMESCO Finland

Total nephrectomy with capsule

13.8

11.8

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

9.4

11.8

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.7

11.7

275

3695

4040

NOMESCO Finland

15.5

11.7

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

7.6

11.7

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

8.1

11.7

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

4.4

11.6

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.0

11.6

104

OAA67

SPAT

0.3

11.6

654

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

0.5

11.6

106

1786

H01CB03

ATC

lanreotide; parenteral

33.7

11.6

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

7.8

11.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

11.4

146

666

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

0.6

11.4

203

2888

M01AC06

ATC

meloxicam; systemic, rectal

0.8

11.4

1220

13058

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

24.0

11.4

N05AX08

ATC

risperidone; systemic

0.6

11.4

170

2518

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

11.4

102

N81.1

ICD-10 Finland

Cystocele

0.5

11.3

1542

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

0.6

11.2

183

2654

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

0.8

11.2

677

7773

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

11.1

392

2407

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

58.3

11.0

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.0

11.0

133

591

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

0.4

11.0

899

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

11.0

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

11.0

C34.03

ICD-10 Finland

Malignant tumor of the main bronchial bronchoalveolar carcinoma

+∞

11.0

8230/3-C34.1

ICD-O-3

Solid carcinoma, NOS, of upper lobe, lung

+∞

11.0

C32.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of larynx

+∞

11.0

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

11.0

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

11.0

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

11.0

1622A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]

+∞

11.0

8140/3-C34.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of lung

+∞

11.0

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

11.0

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

11.0

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

+∞

11.0

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

11.0

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.6

11.0

130

2039

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

5.4

10.9

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

107.8

10.9

GA3CT

NOMESCO Finland

Pleural cytology with CT guidance

107.8

10.9

GBA35

NOMESCO Finland

Endoscopic insertion of stent into trachea

107.8

10.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

10.9

327

1935

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

0.7

10.9

350

4431

WX111

NOMESCO Finland

Local infiltration anesthesia

0.4

10.9

924

G03HA01

ATC

cyproterone; systemic

9.4

10.9

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

3.2

10.9

153

SPAT1305

SPAT

Counselling and guidance related to physical exercise

0.6

10.8

221

3048

R05CB01

ATC

acetylcysteine; inhalant, oral

2.4

10.7

361

OAB44

SPAT

0.3

10.7

704

R03AC19

ATC

olodaterol; inhalant

4.4

10.7

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.5

10.7

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

31.4

10.7

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.9

10.7

160

776

J98.1

ICD-10 Finland

Pulmonary collapse

3.5

10.7

122

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.7

10.6

113

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

10.6

1138

8375

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

3.2

10.6

151

SPAT1263

SPAT

Sampling

0.8

10.5

1555

16124

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.8

10.5

223

KEB00

NOMESCO Finland

Biopsy of prostate

3.5

10.5

128

UDQ22

NOMESCO Finland

Microlaryngoscopy

3.8

10.5

101

S27.0

ICD-10 Finland

Traumatic pneumothorax

3.3

10.5

138

WW200

NOMESCO Finland

Immunization

2.1

10.5

113

480

SPAT1260

SPAT

Consultation of another employee

0.7

10.5

527

6214

J01DA01

ATC

[U] cefalexin; systemic

1.2

10.4

3005

24546

JN5AP

NOMESCO Finland

Total body PET (1 picture)

38.9

10.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.8

10.3

1400

14649

ZXH06

SPAT

0.3

10.3

585

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

6.5

10.2

WX734

NOMESCO Finland

JET-ventilation

12.4

10.2

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

5.2

10.2

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

2.8

10.1

200

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

53.9

10.1

RS220

NOMESCO Finland

3.1

10.1

162

Z97.4

ICD-10 Finland

Presence of external hearing-aid

0.5

10.1

104

1692

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

10.1

1163

12373

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

10.0

796

8841

R03AC18

ATC

indacaterol; inhalant

2.7

10.0

223

S01ED51

ATC

timolol, combinations; ophthalmic

0.6

10.0

195

2718

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

0.6

10.0

224

3033

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

10.0

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

10.0

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

10.0

8560/3-C34.1

ICD-O-3

Adenosquamous carcinoma of upper lobe, lung

+∞

10.0

8560/3-C34.3

ICD-O-3

Adenosquamous carcinoma of lower lobe, lung

+∞

10.0

L02BX03

ATC

abiraterone; oral

+∞

10.0

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

+∞

10.0

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

10.0

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

10.0

8013/3-C34.3

ICD-O-3

Large cell neuroendocrine carcinoma of lower lobe, lung

+∞

10.0

8000/3-C34.2

ICD-O-3

Neoplasm, malignant of middle lobe, lung

+∞

10.0

C43.12

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type

+∞

10.0

C34.07

ICD-10 Finland

Malignant tumor of the main bronchus carcinoid

+∞

10.0

8020/3-C34.1

ICD-O-3

Carcinoma, undifferentiated, NOS, of upper lobe, lung

+∞

10.0

1628A

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]

+∞

10.0

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

10.0

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

10.0

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

10.0

L02BB04

ATC

enzalutamide; oral

+∞

10.0

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

10.0

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.0

C34.94

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary macrocellular anaplastic carcinoma

+∞

10.0

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

10.0

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.3

10.0

364

S12

ICPC

Insect bite/sting

0.6

10.0

163

2361

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

98.8

9.9

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

9.9

163

813

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.1

9.9

154

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

0.6

9.9

176

2505

L02AE03

ATC

goserelin; implant

7.9

9.9

C08CA13

ATC

lercanidipine; oral

0.7

9.8

410

4975

SAA03

NOMESCO Finland

Extended examination of mouth

0.8

9.8

1049

11264

K04.1

ICD-10 Finland

Necrosis of pulp

0.6

9.8

169

2423

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.8

9.8

153

753

TDA90

SPAT

0.3

9.8

675

SPAT1377

SPAT

Polysomnography

0.3

9.8

701

KC1GB

NOMESCO Finland

Cystography with X-ray

10.0

9.8

N05BA01

ATC

diazepam; systemic, rectal

1.4

9.8

594

4032

SPAT1324

SPAT

Screening procedure

0.6

9.8

146

2161

L12

ICPC

Hand/finger symptom/complaint

0.7

9.7

314

3975

R5140

NOMESCO Finland

Monitoring the use of the aid

0.7

9.7

254

3342

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.0

9.7

H61.2

ICD-10 Finland

Impacted cerumen

0.6

9.7

106

1698

G30.8

ICD-10 Finland

Other Alzheimer disease

0.3

9.7

686

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

20.9

9.7

N06DA04

ATC

galantamine; oral

0.3

9.6

700

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.1

9.6

103

439

Z96.1

ICD-10 Finland

Presence of intraocular lens

0.7

9.6

439

5253

L01

ICPC

Neck symptom/complaint

0.7

9.6

286

3670

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

0.7

9.6

293

3740

AXX01

SPAT

0.2

9.6

410

B35.1

ICD-10 Finland

Tinea unguium

0.5

9.5

1452

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

9.5

179

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.1

9.5

144

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.5

9.5

1042

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

2.7

9.5

206

ZZA50

NOMESCO Finland

Full thickness skin graft

11.8

9.5

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

7.3

9.5

WZC00

SPAT

0.4

9.5

964

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

0.7

9.5

257

3355

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.5

9.4

100

1614

A10BJ06

ATC

semaglutide; parenteral

0.3

9.4

677

L16

ICPC

Ankle symptom/complaint

0.6

9.4

197

2707

ZXA05

NOMESCO Finland

Left side

1.2

9.4

1257

9486

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

9.3

479

3163

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

23.3

9.3

J98.4

ICD-10 Finland

Other disorders of lung

7.1

9.3

N04BC05

ATC

pramipexole; oral

0.6

9.2

166

2354

R83

ICPC

Respiratory infection other

0.7

9.2

348

4287

D14.3

ICD-10 Finland

Benign neoplasm: Bronchus and lung

5.6

9.2

H81

ICPC

Excessive ear wax

0.8

9.2

578

6613

GDA20

NOMESCO Finland

Excision of lesion of lung

10.9

9.2

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

10.9

9.2

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.7

9.1

221

2947

P06

ICPC

Sleep disturbance

0.6

9.1

164

2328

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

9.1

208

1151

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.6

9.1

170

2388

R4110

SPAT

0.3

9.1

620

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

0.7

9.0

242

3165

K02.0

ICD-10 Finland

Caries limited to enamel

0.6

9.0

157

2243

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

0.6

9.0

184

2540

R42

ICD-10 Finland

Dizziness and giddiness

0.8

9.0

737

8166

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.9

9.0

165

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

9.0

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

9.0

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

9.0

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.0

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

9.0

C38.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura

+∞

9.0

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

+∞

9.0

C04.0

ICD-10 Finland

Malignant neoplasm: Anterior floor of mouth

+∞

9.0

L01EB02

ATC

erlotinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)

+∞

9.0

8550/3-C34.3

ICD-O-3

Acinar cell carcinoma of lower lobe, lung

+∞

9.0

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

9.0

8070/3-C34.8

ICD-O-3

Squamous cell carcinoma, NOS, of overlapping lesion of lung

+∞

9.0

C34.23

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma

+∞

9.0

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

9.0

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

9.0

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

+∞

9.0

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

9.0

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

9.0

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

9.0

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

9.0

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

9.0

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

9.0

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

9.0

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

9.0

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

+∞

9.0

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

9.0

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

89.8

9.0

GEB40

NOMESCO Finland

Mediastinotomy and extended excision of lesion

89.8

9.0

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

89.8

9.0

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

89.8

9.0

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.8

9.0

1169

12315

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.5

9.0

1196

K85

ICPC

Elevated blood pressure

0.7

8.9

485

5661

ZXC40

NOMESCO Finland

Use of ultrasound

4.9

8.9

WZC30

SPAT

0.3

8.9

493

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.6

8.9

223

H25.0

ICD-10 Finland

Senile incipient cataract

0.6

8.9

149

2148

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

8.9

187

1010

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.2

8.9

122

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

5.3

8.9

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

0.7

8.9

295

3711

D01AE16

ATC

amorolfine; topical

0.7

8.8

306

3828

SPAT1153

SPAT

Removal of sutures

0.8

8.8

1096

11602

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.5

8.8

1126

SPAT1290

SPAT

Preparation of deceased person

8.1

8.8

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.6

8.7

107

1662

M02AA10

ATC

ketoprofen; topical

0.7

8.7

440

5190

RS222

NOMESCO Finland

2.6

8.7

212

N05CD07

ATC

temazepam; oral

1.3

8.7

653

4580

H26.4

ICD-10 Finland

After-cataract

0.7

8.6

260

3329

H43.8

ICD-10 Finland

Other disorders of vitreous body

0.7

8.6

198

2670

P17

ICPC

Tobacco abuse

2.7

8.6

186

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

8.6

1116

11766

XG466

NOMESCO Finland

Sleep oxymetry

1.7

8.6

169

899

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

32.9

8.5

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

7.8

8.5

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

0.6

8.5

119

1786

SPAT1304

SPAT

Counselling and guidance related to ageing

0.7

8.5

202

2702

GWW96

NOMESCO Finland

Other reoperation in thoracic surgery

14.0

8.5

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

0.6

8.4

124

1842

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

21.5

8.4

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

21.5

8.4

Z57.2

ICD-10 Finland

Occupational exposure to dust

3.5

8.4

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.2

8.4

330

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

9.0

8.3

SGC00

NOMESCO Finland

Local medication of root channels of tooth

0.6

8.3

157

2204

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

6.0

8.3

S29

ICPC

Skin symptom/complaint other

0.7

8.3

449

5245

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

11.2

8.3

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

4.5

8.3

R92

ICPC

Neoplasm respiratory unspecified

44.9

8.2

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.6

8.2

198

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.8

8.2

1106

11621

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.5

8.2

214

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

6.7

8.2

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

8.1

192

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

0.7

8.1

410

4841

CJB10

NOMESCO Finland

Laser discission of secondary cataract

0.7

8.1

221

2881

WGA11

NOMESCO Finland

Planning of pain management

12.6

8.1

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

8.1

460

3089

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

8.5

8.1

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

8.5

8.1

K62.7

ICD-10 Finland

Radiation proctitis

80.8

8.0

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

24.7

8.0

TQW20

NOMESCO Finland

Tatoe

14.6

8.0

R03BB07

ATC

umeclidinium bromide; inhalant

2.8

8.0

167

8020/3-C34.3

ICD-O-3

Carcinoma, undifferentiated, NOS, of lower lobe, lung

+∞

8.0

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

8.0

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

8.0

DQE00

NOMESCO Finland

Implantation of prosthetic replacement for larynx

+∞

8.0

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

+∞

8.0

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

8.0

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

8.0

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

8.0

8071/3-C34.1

ICD-O-3

Squamous cell carcinoma, keratinizing, NOS, of upper lobe, lung

+∞

8.0

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

8.0

9591/3-C34.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lung, NOS

+∞

8.0

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

8.0

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

8.0

8260/3-C34.1

ICD-O-3

Papillary adenocarcinoma, NOS, of upper lobe, lung

+∞

8.0

L01ED01

ATC

crizotinib; oral

+∞

8.0

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

8.0

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

8.0

L04AX04

ATC

lenalidomide; oral

+∞

8.0

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

+∞

8.0

1625B

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]

+∞

8.0

8072/3-C34.3

ICD-O-3

Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of lower lobe, lung

+∞

8.0

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

8.0

C79.40

ICD-10 Finland

Secondary malignant tumor of the spinal cord

+∞

8.0

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

8.0

DQB30

NOMESCO Finland

Laryngectomy

+∞

8.0

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

8.0

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

+∞

8.0

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

8.0

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

8.0

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

8.0

N17

ICPC

Vertigo/dizziness

0.7

8.0

294

3637

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

2.6

8.0

189

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

8.0

135

685

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

6.4

8.0

5702

FHL

Local lymph node removal (eg armpit, groin)

18.0

8.0

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

10.4

8.0

F05.1

ICD-10 Finland

Delirium superimposed on dementia

0.0

8.0

178

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

7.9

129

645

SPAT1111

SPAT

Planning of analgesia

2.6

7.9

190

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

0.6

7.9

138

1969

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

7.9

1365

10549

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

0.8

7.9

457

5291

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

7.4

7.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

0.8

7.8

467

5389

R01AD08

ATC

fluticasone; nasal

0.8

7.8

747

8140

A69.2

ICD-10 Finland

Lyme disease

0.5

7.8

1278

U02

ICPC

Urinary frequency/urgency

0.7

7.8

299

3673

U07

ICPC

Urine symptom/complaint other

0.6

7.8

107

1613

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

0.2

7.8

312

WZA90

NOMESCO Finland

Other doctors statement

0.8

7.8

597

6667

5188X

ICD-9 Finland

Other diseases of lung

5.2

7.7

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.2

7.7

K03.00

ICD-10 Finland

Approximal wear

0.5

7.7

995

C09DA01

ATC

losartan and diuretics; oral

0.7

7.7

299

3669

C10AA01

ATC

simvastatin; oral

0.9

7.7

2329

22873

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.7

7.7

249

3145

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

7.0

7.7

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.8

7.7

121

600

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

29.9

7.7

A21

ICPC

Risk factor for malignancy

29.9

7.7

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

29.9

7.7

N04BC04

ATC

ropinirole; oral

0.2

7.6

287

R2110

NOMESCO Finland

Giving the first information

1.5

7.6

234

1395

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.6

7.6

190

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

7.6

285

1777

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

0.6

7.6

101

1533

M02AA07

ATC

piroxicam; topical

0.8

7.6

1415

14454

TKE10

NOMESCO Finland

Puncture of prostate

15.4

7.6

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

19.7

7.6

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

19.7

7.6

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

0.7

7.5

287

3534

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

0.4

7.5

610

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

7.5

361

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

7.5

442

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

7.5

249

1509

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

7.5

653

7195

ZX114

NOMESCO Finland

Intramuscular

2.6

7.5

186

K05.1

ICD-10 Finland

Chronic gingivitis

0.6

7.5

1439

5561

FHL

Aortoil cavity endarterectomy

10.5

7.5

R03AC12

ATC

salmeterol; inhalant

1.5

7.5

225

1335

R03BA02

ATC

budesonide; inhalant

1.3

7.5

712

5148

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

0.4

7.5

769

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.8

7.5

144

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.3

7.5

433

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

4.5

7.4

SGA05

NOMESCO Finland

Very demanding and lengthy opening and dilatation of root canal of tooth

0.5

7.4

909

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

0.5

7.4

807

1243

FHL

Bronchoscopy and other therapeutic procedure

9.0

7.4

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.0

7.4

438

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

0.6

7.4

1307

S22

ICPC

Nail symptom/complaint

0.6

7.4

111

1637

L01AA02

ATC

chlorambucil; oral

11.7

7.3

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

1.9

7.3

441

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

1.8

7.3

127

650

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

0.6

7.3

139

1941

N05AB01

ATC

dixyrazine; systemic

2.3

7.3

253

R25.1

ICD-10 Finland

Tremor, unspecified

0.4

7.2

762

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

7.2

139

734

R01AD01

ATC

beclometasone; nasal

0.7

7.2

347

4124

GAC46

NOMESCO Finland

Partial decortication of pleura

6.9

7.2

R35

ICD-10 Finland

Polyuria

0.7

7.2

164

2213

H29

ICPC

Ear symptom/complaint other

0.7

7.2

260

3230

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

2.7

7.2

158

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

0.6

7.2

139

1940

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

7.2

417

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.9

7.2

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

7.2

1177

M79.1

ICD-10 Finland

Myalgia

0.7

7.2

258

3206

G04CA01

ATC

alfuzosin; oral

0.8

7.2

451

5167

K08.80

ICD-10 Finland

Toothache NOS

0.6

7.2

1419

DAB10

NOMESCO Finland

Partial excision of auricle

22.4

7.2

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

22.4

7.2

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

22.4

7.2

GCA08

NOMESCO Finland

Bronchoscopic excsion of lesion of bronchus

16.5

7.1

N04BD02

ATC

rasagiline; oral

0.1

7.1

214

G03AC03

ATC

levonorgestrel; systemic

0.6

7.1

109

1598

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

0.6

7.1

116

1677

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

71.9

7.1

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

71.9

7.1

L02BB01

ATC

flutamide; oral

71.9

7.1

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

71.9

7.1

D77

ICPC

Malignant digestive neopl other/NOS

71.9

7.1

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

71.9

7.1

S01EE05

ATC

tafluprost; ophthalmic

0.5

7.1

1014

K78

ICPC

Atrial fibrillation/flutter

0.7

7.1

265

3267

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.6

7.0

DFF15

NOMESCO Finland

Speech audiometry

0.6

7.0

1424

S18

ICPC

Laceration/cut

0.8

7.0

1558

15711

A97

ICPC

No disease

0.8

7.0

413

4774

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

0.6

7.0

148

2023

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.9

7.0

129

1625C

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]

+∞

7.0

8022/3-C34.3

ICD-O-3

Pleomorphic carcinoma of lower lobe, lung

+∞

7.0

GDC23

NOMESCO Finland

Lobectomy and segment resection of lung

+∞

7.0

C79.49

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified parts of nervous system

+∞

7.0

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.0

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

7.0

1624B

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA MICROCELLURE]

+∞

7.0

8230/3-C34.3

ICD-O-3

Solid carcinoma, NOS, of lower lobe, lung

+∞

7.0

1629X

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]

+∞

7.0

8070/3-C04.9

ICD-O-3

Squamous cell carcinoma, NOS, of floor of mouth, NOS

+∞

7.0

1501

Kela drug reimbursment

Palbociclib

+∞

7.0

L71

ICPC

Malignant neoplasm musculoskeletal

+∞

7.0

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

7.0

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

7.0

C13.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of hypopharynx

+∞

7.0

8260/3-C34.3

ICD-O-3

Papillary adenocarcinoma, NOS, of lower lobe, lung

+∞

7.0

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

7.0

8070/3-C01.9

ICD-O-3

Squamous cell carcinoma, NOS, of base of tongue, NOS

+∞

7.0

1625F

ICD-9 Finland

Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,MUU HISTOLOGIA]

+∞

7.0

C79.41

ICD-10 Finland

Secondary malignant tumor of optic nerve and eye

+∞

7.0

8072/3-C34.1

ICD-O-3

Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of upper lobe, lung

+∞

7.0

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

7.0

8010/3-C34.2

ICD-O-3

Carcinoma, NOS, of middle lobe, lung

+∞

7.0

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

7.0

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

7.0

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

+∞

7.0

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

7.0

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

7.0

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

7.0

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

7.0

GD3CT

NOMESCO Finland

Labeling lungs with CT guidance

+∞

7.0

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

7.0

394

Kela drug reimbursment

Palbociclib

+∞

7.0

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

7.0

3017

Kela drug reimbursment

Brigatinib

+∞

7.0

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

0.6

7.0

110

1605

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

9.0

7.0

KAD00

NOMESCO Finland

Partial nephrectomy

7.2

7.0

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

7.0

310

2000

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.4

7.0

204

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.4

6.9

212

SPAT1058

SPAT

PEF monitoring instruction

0.7

6.9

198

2558

114

Kela drug reimbursment

Glaucoma

0.7

6.9

283

3445

A02BX05

ATC

bismuth subcitrate; oral

2.0

6.9

398

Y85

ICPC

Benign prostatic hypertrophy

0.4

6.9

575

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

0.7

6.9

175

2313

XF600

SPAT

0.1

6.9

211

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

0.8

6.9

504

5670

H91.9

ICD-10 Finland

Hearing loss, unspecified

0.6

6.9

1268

Z25.1

ICD-10 Finland

Need for immunization against influenza

0.6

6.9

104

1529

SPAT1101

SPAT

Orthostatic test

0.6

6.9

111

1608

R01AD09

ATC

mometasone; nasal

0.8

6.9

1355

13799

K76

ICPC

Ischaemic heart dis without angina

0.5

6.9

932

J01CA08

ATC

pivmecillinam; oral

0.8

6.8

967

10136

M10.9

ICD-10 Finland

Gout, unspecified

0.7

6.8

204

2614

205

Kela drug reimbursment

Chronic hypertension

0.8

6.8

1354

13779

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

14.1

6.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

9.7

6.8

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

9.7

6.8

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.0

6.8

339

XGX10

NOMESCO Finland

Intrapleural ultrasonography

26.9

6.8

J18

ICD-10 Finland

Pneumonia, organism unspecified

2.7

6.8

148

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

2.7

6.8

148

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

2.5

6.7

170

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

6.7

395

4565

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

7.5

6.7

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.8

6.7

1116

11534

A96

ICPC

Death

3.0

6.7

108

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

3.5

6.7

Z00.8

ICD-10 Finland

Other general examinations

0.6

6.7

116

1653

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.7

6.6

156

2088

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

6.6

348

H25.1

ICD-10 Finland

Senile nuclear cataract

0.8

6.6

1170

12029

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

2.3

6.6

217

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

10.8

6.6

J02AC02

ATC

itraconazole; systemic

0.8

6.6

455

5152

M76.6

ICD-10 Finland

Achilles tendinitis

0.5

6.6

994

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

6.6

104

518

WX723

NOMESCO Finland

CPAP therapy

0.5

6.5

707

KED52

NOMESCO Finland

Visual laser resection of prostate

0.4

6.5

524

C05AA08

ATC

fluocortolone; rectal, topical

0.8

6.5

376

4359

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

4.2

6.5

I49.5

ICD-10 Finland

Sick sinus syndrome

0.6

6.5

1305

R03BB02

ATC

oxitropium bromide; inhalant

2.6

6.5

153

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

12.3

6.4

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

12.3

6.4

153

Kela drug reimbursment

Lenalidomid

35.9

6.4

D09.0

ICD-10 Finland

Carcinoma in situ: Bladder

35.9

6.4

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

4.1

6.4

CKC12

NOMESCO Finland

Photocoagulation of retina

0.6

6.4

1129

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

2.9

6.4

116

ZX136

NOMESCO Finland

Intravesicalis

3.8

6.4

J20

ICD-10 Finland

Acute bronchitis

1.3

6.4

373

2521

R05FB02

ATC

cough suppressants and expectorants

1.2

6.4

1806

14533

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

0.6

6.3

135

1844

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.7

6.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

6.3

198

1190

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

1.8

6.3

106

541

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

9.8

6.3

ZXC20

NOMESCO Finland

Use of chemical agents

2.2

6.3

258

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

0.7

6.3

227

2818

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

7.4

6.3

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

8.3

6.3

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

0.7

6.3

137

1862

NF1AA

SPAT

0.2

6.3

271

ZZR10

NOMESCO Finland

Flap of skin and muscle

5.2

6.3

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.7

6.2

272

3276

193

Kela drug reimbursment

Rasagiline

0.1

6.2

171

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.3

6.2

J43.8

ICD-10 Finland

Other emphysema

3.6

6.2

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.1

6.2

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

0.4

6.2

525

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.0

6.2

353

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

0.6

6.2

1126

A41.9

ICD-10 Finland

Sepsis, unspecified

1.6

6.2

158

905

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

62.9

6.1

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

62.9

6.1

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

62.9

6.1

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

62.9

6.1

GDA96

NOMESCO Finland

Other incision, excision of lesion or repair of lung

62.9

6.1

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

62.9

6.1

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.3

6.1

198

R06.5

ICD-10 Finland

Mouth breathing

0.7

6.1

178

2288

S82

ICPC

Naevus/mole

0.7

6.1

257

3114

1XC02

NOMESCO Finland

3.8

6.1

ACC51

NOMESCO Finland

Release of median nerve

0.6

6.1

130

1774

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

4.5

6.1

C08CA01

ATC

amlodipine; oral

0.9

6.1

1639

16323

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

0.7

6.1

144

1924

N39.4

ICD-10 Finland

Other specified urinary incontinence

0.7

6.1

176

2268

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.7

6.1

170

2204

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

0.3

6.1

435

PDH54

NOMESCO Finland

Bypass from aorta to bilateral femoral arteries

3.9

6.1

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

7.8

6.0

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

3.1

6.0

WX290

NOMESCO Finland

Other blockade of nerve

0.8

6.0

1091

11208

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

0.8

6.0

415

4698

H91.1

ICD-10 Finland

Presbycusis

0.7

6.0

173

2229

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

0.4

6.0

569

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

6.0

429

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

3.5

6.0

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

6.0

193

1169

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

0.5

6.0

907

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1937

6465

2.88

322.70

4.2

2.5

u/l

256.0

243.6

2.16

1881

5953

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

495

564

7.67

316.90

1.2

1.3

u/l

733.1

285.8

2.64

483

526

(4035726)

2685

1652

18.51

307.65

1.4

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4633

57880

0.35

307.65

3.9

4.9

mmol/l

4.4

0.05

4032

52721

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4837

59442

0.34

307.65

4.3

5.6

mmol/l

2.6

1.03

4149

53897

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4450

55456

0.38

307.65

3.5

4.4

mmol/l

1.3

5.01

3791

49605

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4555

57344

0.35

307.65

3.9

4.9

mmol/l

1.4

10.04

3916

51790

(40768806) Pleura Pathology biopsy report

608

612

8.78

307.65

1.5

—

(3024731) MCV [Entitic volume]

5899

63765

0.39

307.65

41.8

21.5

91.7

0.65

5788

62346

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2288

3475

6.92

307.65

3.4

1.4

ug/l

58.3

7.6

5.79

2089

2620

(3000963) Hemoglobin [Mass/volume] in Blood

5899

63778

0.39

307.65

42.2

21.7

g/l

126.1

135.4

307.65

5793

62364

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4540

56517

0.37

307.65

5.8

6.8

mmol/mol

41.4

41.1

1.16

3978

51476

(3035637) Corticotropin [Mass/volume] in Plasma

512

435

10.32

307.65

1.6

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1372

370

35.98

307.65

2.1

1.3

ug/l

31.4

19.9

3.50

1355

356

(3042631) Mycobacterium sp identified in Specimen

706

870

7.23

307.65

1.9

2.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4966

58409

0.39

307.65

4.9

5.2

mmol/l

6.2

6.1

2.18

4342

52157

(3023199) Leukocytes [#/volume] in Pleural fluid

606

759

7.04

307.65

1.4

1.5

e6/l

2746.9

2671.3

0.04

443

564

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1439

612

22.94

307.65

1.2

1.1

—

(3035941) MCH [Entitic mass]

5898

63764

0.39

307.65

41.7

21.4

30.1

30.5

38.75

5786

62345

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

755

752

9.01

307.65

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

678

858

7.02

307.65

1.4

1.5

g/l

38.5

29.1

53.27

636

751

(3026361) Erythrocytes [#/volume] in Blood

5898

63771

0.39

307.65

41.9

21.5

e12/l

4.2

4.5

188.46

5691

61166

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1363

1201

10.88

307.65

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

545

649

7.37

307.65

1.4

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1437

2137

6.43

307.65

2.3

2.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

564

684

7.25

307.65

1.4

1.5

e6/l

72936.9

67198.3

0.10

349

409

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2608

9016

2.95

307.65

4.3

2.4

mmol/l

0.8

50.51

2519

8204

(3010813) Leukocytes [#/volume] in Blood

5901

63782

0.39

307.65

41.9

21.6

e9/l

8.1

6.9

106.06

5692

61201

(3007461) Platelets [#/volume] in Blood

5899

63751

0.40

307.65

41.9

21.5

e9/l

268.3

238.3

141.27

5720

61457

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5793

61766

0.44

296.46

18.6

9.6

u/l

25.4

25.2

0.06

5676

58683

(3023103) Potassium [Moles/volume] in Serum or Plasma

5879

62288

0.44

293.89

32.5

18.2

mmol/l

4.0

2.35

5734

60351

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

300

+∞

292.94

1.1

0.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

423

437

8.40

292.77

1.2

1.3

u/l

12.8

11.5

0.60

410

395

(3019550) Sodium [Moles/volume] in Serum or Plasma

5879

62174

0.44

287.76

32.4

18.1

mmol/l

138.3

139.8

208.91

5748

60329

(3036782) Glucose [Moles/volume] in Pleural fluid

462

548

7.34

285.63

1.3

1.4

mmol/l

6.0

6.7

3.95

439

501

(3045788) Cell count panel - Pleural fluid

462

577

6.97

272.95

1.4

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4744

53717

0.47

264.48

5.5

4.6

mu/l

1.9

2.1

3.98

4211

47968

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

336

310

9.33

252.81

1.2

1.3

—

(40761511) CBC panel - Blood by Automated count

5624

59574

0.48

245.15

25.4

14.5

—

(40768804) Tissue Pathology biopsy report

3580

17680

2.11

240.26

2.7

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1357

4462

2.79

226.28

5.3

1.8

nmol/l

427.9

368.5

14.66

1303

3982

(3023368) Bacteria identified in Blood by Culture

3532

17897

2.03

215.48

4.9

4.0

—

(42870588) Differential panel, method unspecified - Blood

3733

19321

2.01

214.33

6.7

5.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

356

436

7.04

213.59

1.3

1.4

u/l

11.1

13.7

9.79

343

416

(3002256) Pathology report gross observation

1322

4461

2.71

208.78

1.4

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

176

21.04

206.42

2.9

1.0

u/ml

44.8

17.3

2.63

168

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5007

29148

1.92

198.61

10.5

3.8

umol/l

10.2

12.5

21.98

4888

27194

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5154

54700

0.53

186.08

29.0

13.7

ml/min/173m2

76.9

73.1

34.59

4595

44035

(3013650) Neutrophils [#/volume] in Blood by Automated count

5193

31031

1.87

184.64

14.9

6.0

e9/l

5.0

4.4

31.61

4620

26342

(3035880) pH of Pleural fluid

293

345

7.28

181.75

1.2

1.3

—

(3022096) Basophils/100 leukocytes in Blood

4433

25457

1.85

175.59

7.1

5.5

0.6

0.7

9.50

4315

23297

(3018418) pH of Serum or Plasma

3375

18024

1.87

165.70

5.3

3.4

7.4

2.11

599

3185

(3019069) Monocytes/100 leukocytes in Blood

4506

26331

1.81

165.19

7.3

5.7

9.0

8.9

1.65

4384

24158

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1019

3384

2.69

163.95

8.2

8.6

mmol/l

25.0

24.4

7.55

982

3052

(3006504) Eosinophils/100 leukocytes in Blood

4477

26205

1.80

162.21

7.1

5.4

2.4

3.0

55.78

4356

23939

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

871

16351

0.39

156.43

1.6

mmol/l

1.4

1.3

2.05

740

13356

(3002030) Lymphocytes/100 leukocytes in Blood

4529

26834

1.78

155.04

7.2

5.6

22.0

26.3

121.59

4398

24445

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1025

3528

2.60

153.13

6.9

7.0

mmol/l

25.8

24.7

16.07

1017

3481

(3033658) Prothrombin time (PT) actual/Normal

2741

13969

1.89

153.08

5.4

3.6

90.4

83.3

42.68

2699

13609

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2132

10008

2.00

151.41

2.0

1.9

29.9

30.2

1.75

2093

9694

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3903

43465

0.57

142.41

4.7

3.7

pmol/l

15.3

15.0

5.57

3515

38508

(3018010) Neutrophils/100 leukocytes in Blood

4419

26539

1.73

138.84

7.0

5.4

62.4

58.5

78.04

4298

24332

(4010399)

1206

4673

2.32

138.76

1.4

1.5

—

(3001604) Monocytes [#/volume] in Blood

4617

28141

1.72

136.76

6.9

5.2

e9/l

0.7

0.6

58.04

4002

23792

(3003396) Base excess in Arterial blood by calculation

1721

7732

2.05

136.41

7.3

6.7

mmol/l

1.6

1.3

3.19

1455

5954

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2260

11173

1.90

135.85

5.3

2.2

mmol/l

2.5

91.32

2064

9498

(3006315) Basophils [#/volume] in Blood

4634

28350

1.71

134.63

6.9

5.2

e9/l

0.0

2.20

4026

24005

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1720

7768

2.03

134.17

7.3

6.7

kpa

5.4

5.0

28.15

1625

7376

(3027801) Oxygen [Partial pressure] in Arterial blood

1716

7762

2.03

133.19

7.3

6.7

kpa

11.2

11.4

0.97

1623

7359

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

348

662

4.51

131.78

3.2

3.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1669

23269

0.51

128.51

3.8

4.0

mg/mmol

12.9

9.2

1.81

1061

14880

(3019198) Lymphocytes [#/volume] in Blood

4660

28852

1.68

126.54

7.0

5.3

e9/l

1.7

1.8

1.00

4092

24832

(3013115) Eosinophils [#/volume] in Blood

4705

29249

1.68

125.37

7.2

5.3

e9/l

0.2

7.90

4121

25111

(3032080) INR in Blood by Coagulation assay

4420

27040

1.68

125.09

7.9

11.4

inr

1.2

1.4

11.18

941

7366

(3009508) Creatinine [Moles/volume] in Urine

1570

22177

0.51

125.06

2.9

3.2

mmol/l

7.1

7.4

1.49

1237

18354

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

125

14.66

125.01

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5869

58097

0.59

124.47

31.3

14.7

mg/l

37.5

25.8

111.23

5590

46284

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4576

28354

1.67

122.36

7.9

5.4

mmol/l

1.2

4.72

4372

24931

(3012516) Albumin [Mass/volume] in Urine

1559

21940

0.51

121.94

3.0

3.3

mg/l

517.6

264.0

1.24

1023

14137

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

170

167

8.62

121.87

1.2

ug/l

579.9

49.0

4.03

136

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2348

29248

0.56

121.19

4.3

4.1

ug/l

2.5

2.6

0.19

1995

25971

(3003338) MCHC [Mass/volume]

4413

46763

0.60

121.15

38.7

19.6

g/l

328.4

332.1

114.40

4345

46276

(40758558) Short blood count panel - Blood

2495

13115

1.80

121.08

11.1

4.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

360

759

4.07

119.54

1.3

u/l

14.6

9.7

5.80

295

599

(3024561) Albumin [Mass/volume] in Serum or Plasma

4220

25750

1.66

118.37

6.0

3.8

g/l

32.7

35.0

109.23

3995

23367

(3015377) Calcium [Moles/volume] in Serum or Plasma

3327

19105

1.70

117.33

5.5

2.1

mmol/l

2.4

2.3

12.62

3062

15666

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

904

3315

2.41

116.79

9.4

9.8

—

(40768795) Lymph node Pathology biopsy report

143

117

10.33

116.63

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

168

173

8.23

116.16

1.2

1.3

mmol/l

3.7

3.3

0.71

160

156

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1761

23416

0.54

111.55

3.9

4.0

20.5

24.4

23.63

851

12026

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4884

31266

1.62

110.29

9.0

5.8

mmol/l

1.2

1.58

4221

26032

(3014111) Lactate [Moles/volume] in Serum or Plasma

1293

5646

2.05

108.65

7.1

6.4

mmol/l

1.3

1.4

6.83

1241

5399

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

459

1224

3.24

107.96

2.6

1.8

u/ml

594.6

80.7

1.78

393

989

(1761868) Lipid panel - Serum or Plasma

1088

16683

0.48

107.52

3.1

3.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2110

10887

1.79

106.94

2.0

1.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

178

219

6.89

106.15

1.3

1.4

66.6

64.7

0.26

158

177

(3023419) Bacteria identified in Sputum by Culture

370

881

3.60

103.59

1.8

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2405

28957

0.59

103.26

1.9

2.1

pmol/l

88.8

93.1

4.84

1287

15028

(3001893) Eosinophils/100 leukocytes in Pleural fluid

163

191

7.22

101.42

1.3

1.4

4.1

2.5

1.07

152

158

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

218

352

5.26

99.59

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1717

8482

1.84

99.53

1.9

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

177

233

6.44

99.26

1.3

u/l

26.8

35.9

2.22

170

162

(3044640) Blood type and Crossmatch panel - Blood

2965

17110

1.65

98.55

2.8

2.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2377

13079

1.69

94.06

2.7

2.2

—

(3016502) Oxygen saturation in Arterial blood

1460

7019

1.87

91.51

7.9

7.0

94.8

94.9

0.26

1412

6747

(3009542) Hematocrit [Volume Fraction] of Blood

4958

49784

0.64

90.16

31.7

16.4

37.5

38.9

20.43

3172

30495

(3000919) Neutrophils/100 leukocytes in Pleural fluid

144

172

7.07

88.13

1.3

1.4

16.4

23.3

1.87

139

152

(3000991) Gas panel - Venous blood

1169

5286

1.96

87.84

8.2

7.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

623

2190

2.47

87.46

2.3

2.9

u/ml

0.3

1.11

338

1294

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1318

6230

1.89

86.69

8.4

7.5

g/l

120.7

122.3

2.20

1279

6001

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

413

1210

2.93

82.60

1.5

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

127

142

7.55

82.21

1.3

1.4

18.4

25.7

1.62

113

117

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

424

1266

2.88

81.96

1.5

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

707

2710

2.27

81.58

2.0

1.8

ug/l

1.8

0.04

637

2335

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1504

7584

1.78

79.70

2.0

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2858

17068

1.57

78.41

4.4

2.6

u/l

31.8

35.9

1.29

2749

15916

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1494

7595

1.76

76.72

2.0

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

927

4047

2.01

76.41

9.3

8.6

93.3

0.01

922

4032

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

332

898

3.16

76.10

1.5

1.4

—

(3044889) 12 lead EKG panel

4214

42955

0.67

73.49

4.8

4.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

346

984

3.01

72.85

1.5

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1542

8023

1.72

72.57

7.7

6.3

mmol/l

103.8

104.4

3.58

1511

7795

(3004809) Band form neutrophils/100 leukocytes in Blood

292

753

3.30

72.29

2.5

2.8

1.6

1.3

0.48

247

560

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2047

24081

0.63

70.79

2.0

2.2

nmol/l

75.8

79.0

5.31

1781

20773

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1203

16090

0.57

69.95

2.9

ug/l

0.8

0.7

0.55

831

11572

(3002385) Erythrocyte distribution width [Ratio]

4643

46124

0.69

67.28

36.8

17.6

14.5

13.8

187.56

4569

44859

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

287

785

3.11

64.56

1.6

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

302

866

2.97

62.65

1.5

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

275

757

3.09

61.20

1.5

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

2733

29661

0.67

61.12

3.7

3.8

estimate

0.0

1.60

563

4885

(3035350) Ketones [Presence] in Urine by Test strip

2692

29297

0.67

61.05

3.6

3.8

estimate

0.0

0.50

587

4999

(3021601) Nitrite [Presence] in Urine by Test strip

2691

29258

0.67

60.55

5.0

estimate

0.0

0.80

591

5071

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1937

22478

0.65

60.18

4.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

468

1740

2.31

57.62

1.4

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1207

15188

0.61

52.37

1.6

1.7

pmol/l

17665733.2

29817354.2

0.42

968

12181

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

262

768

2.90

52.29

1.6

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

219

583

3.18

51.54

1.3

iu/l

32.0

33.9

0.30

172

493

(3019060) Gas panel - Arterial blood

964

4809

1.75

51.46

4.4

4.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

960

4811

1.74

50.38

2.8

2.2

u/l

33.6

39.1

1.61

842

4038

(3021960) Folate [Moles/volume] in Serum or Plasma

1393

16729

0.64

48.43

1.5

1.6

nmol/l

19.7

20.0

0.28

1220

14070

(3019150) Specific gravity of Urine by Refractometry

1077

13687

0.61

48.07

4.0

4.3

kg/l

1.0

0.15

199

2129

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

214

588

3.08

47.81

1.7

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

207

559

3.13

47.60

2.7

2.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1072

5638

1.66

46.89

1.9

1.6

g/l

64.8

66.7

11.54

993

4980

(44786800) Granulocytes/100 leukocytes in Body fluid

7.72

45.76

1.3

18.6

22.9

0.44

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

380

1445

2.24

44.30

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

380

1446

2.24

44.23

1.3

1.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

8.01

43.03

1.3

1.4

80.1

69.0

1.53

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

779

3849

1.75

42.68

1.6

1.5

—

(1616796) Gas panel - Central venous blood

381

1478

2.20

42.31

4.0

3.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

153

370

3.49

41.91

1.7

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

344

1289

2.27

41.52

2.6

1.5

u/ml

78.3

28.3

3.67

331

1222

(3037467) Urinalysis macro (dipstick) panel - Urine

4271

41420

0.74

40.89

4.4

4.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

135

306

3.72

40.65

1.7

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

135

308

3.69

40.28

1.7

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1418

16420

0.67

39.77

4.0

4.2

estimate

0.0

0.27

510

4845

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

809

4119

1.70

39.70

1.9

1.7

—

(3012501) Base excess in Blood by calculation

371

1469

2.15

39.15

4.9

4.2

mmol/l

3.0

2.5

2.16

294

979

(3013290) Carbon dioxide [Partial pressure] in Blood

371

1471

2.15

39.01

4.9

4.2

kpa

5.1

5.0

2.05

364

1426

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

833

10772

0.61

38.93

1.2

u/ml

1.9

1.8

0.09

167

2747

(3027315) Oxygen [Partial pressure] in Blood

372

1481

2.14

38.72

4.9

4.2

kpa

8.1

8.3

3.13

365

1435

(3009343) pH of Capillary blood

844

4374

1.67

38.71

4.2

3.5

7.4

0.11

102

549

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

638

8799

0.58

38.50

11.6

7.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

273

955

2.42

38.50

3.7

3.2

61.6

59.1

2.10

273

955

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

179

4.55

38.21

2.6

—

(3017181) Myelocytes/100 leukocytes in Blood

885

4659

1.64

38.18

3.3

3.6

1.2

0.8

4.16

456

1031

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

820

4233

1.67

38.16

4.1

3.5

mmol/l

2.7

1.9

7.24

675

3065

(3041918) Cholesterol [Moles/volume] in Pleural fluid

116

5.57

37.98

1.2

mmol/l

2.0

1.3

4.21

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

847

4438

1.65

37.18

4.2

3.6

kpa

5.3

5.1

5.30

794

4073

(3000492) Spirometry study

885

4717

1.62

36.26

1.7

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

179

522

2.90

36.14

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

613

8393

0.58

35.77

3.7

5.1

32.8

33.2

0.32

401

5523

(3010421) pH of Blood

401

1699

2.01

35.36

4.9

4.1

7.4

0.19

364

1426

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

170

490

2.93

35.05

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

162

458

2.98

34.56

1.7

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

5.93

34.15

1.4

9.4

7.2

0.32

(3011412) CD3 cells [#/volume] in Blood

115

266

3.64

33.71

1.9

e9/l

0.9

1.0

0.20

149

(3026493) Urate [Moles/volume] in Serum or Plasma

1530

17028

0.70

33.49

2.8

2.6

umol/l

3270.7

6414.3

2.82

1279

14305

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

803

4264

1.62

33.30

1.6

—

(3051651) Icteric interference index of Serum or Plasma

126

316

3.36

32.73

4.1

4.0

—

(40768441) Liver Pathology biopsy report

192

4.11

32.67

1.2

—

(3022313) Gas panel - Capillary blood

629

3163

1.70

32.14

4.5

3.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.88

31.82

1.5

2.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

282

1094

2.18

31.34

1.4

1.7

iu/l

3.1

4.4

2.25

335

(3021387) Prolactin [Units/volume] in Serum or Plasma

209

712

2.48

31.25

1.5

1.9

mu/l

315.7

291.0

0.71

204

648

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

155

453

2.88

31.23

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

155

453

2.88

31.23

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

155

453

2.88

31.23

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

369

1587

1.98

31.20

2.1

2.2

g/l

121.4

130.4

6.07

198

1185

(3021440) Promyelocytes/100 leukocytes in Blood

823

4479

1.58

30.73

3.4

3.6

0.2

0.1

2.01

421

958

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

378

5675

0.54

30.46

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

215

757

2.40

29.96

4.4

5.1

iu/ml

545.7

758.5

0.29

106

(3017354) Segmented neutrophils/100 leukocytes in Blood

165

511

2.72

29.88

2.3

2.7

60.3

61.4

0.21

120

333

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

817

4477

1.57

29.58

2.1

2.0

g/l

0.2

0.24

757

4021

(40768793) Breast Pathology biopsy report

107

259

3.47

29.38

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.18

29.23

4.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

174

4.05

28.71

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

744

9261

0.64

28.50

1.2

1.3

iu/ml

57.4

40.5

1.41

227

2867

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

688

8709

0.63

28.45

1.2

u/ml

27.4

15.6

0.74

193

3054

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2728

27300

0.77

28.30

2.6

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3589

25421

1.29

28.20

4.3

3.8

—

(3026782) Osmolality of Urine

1883

12197

1.36

28.08

2.8

2.7

mosm/kgh2o

539.1

556.2

2.74

1634

10180

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

178

3.96

27.87

1.6

2.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

776

4264

1.56

27.71

3.3

3.4

0.7

0.5

1.24

336

763

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

16.72

27.63

1.1

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4748

44289

0.79

27.37

5.1

4.2

mm/h

22.3

13.2

138.34

4484

40357

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

127

4.56

27.36

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

206

743

2.34

27.24

2.4

1.9

u/ml

146.8

436.0

0.67

181

667

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

127

359

2.98

27.19

2.8

4.0

—

(44806118)

174

583

2.52

26.99

1.5

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

225

3.55

26.98

1.7

2.0

32.4

45.7

—

(44790047)

174

584

2.51

26.90

1.5

1.4

—

(44790048)

174

584

2.51

26.90

1.5

1.4

—

(44790049)

174

584

2.51

26.90

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

134

393

2.87

26.89

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2254

23013

0.76

26.74

2.6

2.8

ug/l

232.5

145.9

19.07

2048

20754

(1617658) Protocol used for examination of sentinel lymph nodes

55.14

26.58

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

499

2502

1.70

25.71

2.0

2.3

ug/l

323.1

625.0

1.54

453

2365

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

193

3.70

25.68

1.7

2.0

13.7

17.3

0.89

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

329

4897

0.54

25.58

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

997

5886

1.46

25.20

2.6

2.2

umol/l

9.0

8.6

0.17

865

5043

(40767503) Oxygen content in Capillary blood by calculation

317

1399

1.92

24.90

2.8

2.5

14.8

16.3

6.62

150

758

(3028626) Oxygen [Partial pressure] in Capillary blood

345

1568

1.87

24.78

3.0

2.8

kpa

7.6

7.8

1.28

319

1456

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

171

3.83

24.76

1.2

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

171

3.83

24.76

1.2

1.3

—

(3013512) EKG study

1927

19928

0.76

24.63

4.7

4.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

172

3.80

24.56

1.2

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1343

14600

0.73

24.10

3.2

3.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

107

4.62

23.84

1.6

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3561

33992

0.80

23.32

4.6

3.0

u/l

71.1

51.4

13.26

3290

30611

(3014891) Appearance of Pleural fluid

117

4.37

23.06

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

236

3.24

22.56

1.2

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

236

3.24

22.56

1.2

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

236

3.24

22.56

1.2

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

237

3.22

22.41

1.2

—

(3021901) Oxygen saturation in Capillary blood

300

1356

1.87

21.95

2.9

2.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4895

36634

1.24

21.71

7.2

4.5

mmol/l

6.8

6.9

4.95

4745

34246

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1508

9821

1.33

21.00

3.0

2.8

e6/l

2.4

2.1

0.50

805

5412

(3041096) Erythrocytes [Presence] in Urine by Automated

1386

14737

0.75

21.00

3.8

3.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1391

14781

0.75

20.98

1.8

nmol/l

1071.4

1151.0

2.49

1040

10993

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

560

3041

1.57

20.96

3.0

4.1

mmol/l

24.5

24.2

1.74

525

2680

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

199

3.33

20.54

2.2

1.8

e6/l

499.6

715.7

1.61

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

5.33

19.94

5.1

1.4

u/l

30.5

44.8

0.75

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1979

13463

1.29

19.88

4.7

4.2

ng/l

298.3

573.4

3.09

1736

11522

(40768800) Prostate Pathology biopsy report

147

528

2.34

19.75

1.2

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

5.36

19.60

1.2

mg/l

8.0

7.9

0.02

(3002582) Erythrocytes [#/volume] in Urine

2674

18910

1.25

19.32

3.4

3.1

e6/l

74.4

115.2

1.26

2074

14497

(36304419) Bacteria [Presence] in Urine

2351

16404

1.26

19.05

3.3

3.0

—

(3021589) Normoblasts [#/volume] in Blood

3446

25079

1.23

19.01

13.9

8.9

e9/l

0.0

0.12

2678

20409

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

503

2726

1.57

18.99

1.9

1.8

—

(3003181) Sodium [Moles/volume] in Urine

255

1148

1.88

18.94

1.3

mmol/l

63.6

64.1

0.07

197

921

(3030467) Casts [#/volume] in Urine by Automated count

2456

17244

1.25

18.80

3.3

3.0

e6/l

0.7

0.5

3.17

1872

12928

(3025159) Blasts/100 leukocytes in Blood

723

4244

1.46

18.66

3.5

3.7

0.0

0.3

0.91

363

835

(3052851) Hemolysis interference index of Serum or Plasma

369

1868

1.67

18.37

3.9

3.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

490

2661

1.56

18.34

5.0

3.9

mmol/l

25.9

24.9

8.47

464

2421

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

266

1237

1.82

17.85

1.8

2.2

215.9

199.0

2.42

253

1168

(3015235) Bicarbonate [Moles/volume] in Capillary blood

368

1877

1.66

17.81

3.2

3.0

mmol/l

25.7

24.7

3.05

320

1662

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2649

18854

1.24

17.73

4.3

2.3

u/l

58.7

60.7

0.92

2497

17179

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.52

17.29

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1234

8029

1.32

17.02

4.5

5.4

mmol/l

1.0

1.37

1155

7316

(3020779) Urea [Moles/volume] in Serum or Plasma

944

5902

1.37

16.95

4.9

6.5

mmol/l

9.3

11.5

15.44

888

5512

(3048689) Calprotectin [Mass/mass] in Stool

449

5593

0.65

16.77

1.9

2.1

ug/g

210.2

158.4

1.26

362

4310

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

280

1348

1.75

16.75

1.9

2.2

g/l

4.0

3.6

3.46

267

1268

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

158

3.34

16.57

2.7

2.5

39.9

41.2

0.12

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1695

0.39

16.44

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1409

0.34

16.33

2.6

1.6

mg/l

4.6

3.5

0.34

1007

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

5.36

16.31

1.0

1.2

iu/ml

34.8

16.6

0.40

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

168

2671

0.52

16.20

1.7

1.9

—

(40761535) Cells panel - Urine sediment

474

5742

0.67

15.37

3.6

3.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.69

15.33

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

263

1279

1.74

15.22

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

769

4756

1.38

14.72

1.3

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

145

3.29

14.71

1.2

2.2

u/ml

1911.0

69872.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

287

3816

0.62

14.39

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

140

2269

0.51

14.37

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

144

587

2.06

14.32

2.2

2.4

u/ml

5753.9

14372.3

0.25

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.49

14.22

1.2

u/l

23.7

14.9

1.32

(4034850)

137

2225

0.51

14.16

14.7

11.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

447

2523

1.50

14.05

1.8

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

324

2.43

13.96

1.9

2.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

266

3562

0.61

13.74

2.3

2.4

au/ml

23.3

25.3

0.11

106

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

233

3217

0.59

13.65

1.2

1.3

au/ml

52.7

52.4

0.00

127

(3051611) Lipemic interference index of Serum or Plasma

154

657

1.97

13.54

3.9

3.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

415

2341

1.50

13.10

1.2

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

797

5063

1.34

12.83

5.6

3.1

mmol/l

1.2

1.63

752

4258

(21494755) Public health laboratory ask at order entry panel

123

2001

0.51

12.81

1.3

1.4

—

(3045414) Leukocytes [Presence] in Urine

196

2781

0.58

12.78

1.9

—

(36660697) Celiac disease serology panel - Serum

307

3904

0.64

12.62

1.2

—

(3036489) Thrombin time

339

1870

1.53

11.92

1.7

1.8

22.2

21.6

0.54

318

1653

(3008152) Bicarbonate [Moles/volume] in Arterial blood

715

4523

1.34

11.83

7.4

6.9

mmol/l

25.6

24.5

13.12

670

4223

(3002032) Base excess in Venous blood by calculation

979

6475

1.29

11.77

3.4

3.7

mmol/l

2.4

1.9

3.72

817

5250

(3008295) Osmolality of Serum or Plasma

130

553

1.97

11.60

1.3

1.4

mosm/kgh2o

269.9

276.6

2.34

101

412

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

150

2.96

11.56

3.5

1.1

u/ml

66.6

143.5

0.52

(3047181) Lactate [Moles/volume] in Blood

361

2038

1.50

11.39

6.8

6.1

mmol/l

1.2

1.3

4.26

312

1822

(3021447) Carbon dioxide [Partial pressure] in Venous blood

975

6485

1.28

11.20

3.4

3.7

kpa

5.9

1.34

937

6274

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

191

2.67

11.09

2.1

1.7

e6/l

456.2

427.5

0.19

165

(3039443) Prostate specific Ag panel - Serum or Plasma

1026

0.37

10.94

1.4

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

135

2030

0.55

10.92

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

100

3.35

10.69

2.0

1.5

u/l

16.3

46.9

1.05

(4281824)

250

2.41

10.63

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

871

9070

0.78

10.52

1.4

1.3

g/l

2.7

0.05

498

4961

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

238

1260

1.59

10.08

1.4

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1180

0.44

9.89

1.6

1.7

—

(3000494) Fungus identified in Specimen by Culture

987

6679

1.26

9.81

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

1031

0.41

9.72

1.4

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2970

22315

1.16

9.53

3.4

3.2

—

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4451

39817

0.87

9.47

4.6

4.5

e6/l

221.5

1474.2

4.99

705

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1500

10693

1.20

9.01

2.9

2.6

e6/l

1.1

1.2

0.06

796

6239

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1029

0.43

8.92

1.6

1.3

—

(4094501)

115

1699

0.56

8.82

1.1

—

(3039000) Anion gap in Blood

260

1456

1.50

8.63

7.6

6.9

mmol/l

10.4

11.4

5.84

229

1319

(3018572) Chloride [Moles/volume] in Blood

260

1456

1.50

8.63

7.6

6.9

mmol/l

103.7

104.9

3.44

229

1319

(3045142) Bone marrow Pathology biopsy report

101

439

1.93

8.59

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1226

0.49

8.52

1.1

u/ml

38.9

9.8

—

(4015189)

228

2.24

7.75

1.8

2.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

960

0.46

7.71

1.5

69.5

61.8

0.98

607

(3008898) HLA-B27 [Presence]

1172

0.51

7.68

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

312

1855

1.42

7.64

1.2

—

(3028433) Virus identified in Specimen by Culture

173

2.42

7.56

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2917

26533

0.88

7.29

4.6

4.1

ng/l

45.7

98.9

3.15

2407

20209

(3027945) Reticulocytes/100 erythrocytes in Blood

1113

7866

1.20

7.26

2.2

2.0

1.8

1.7

1.34

992

6779

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

608

4026

1.28

7.25

1.3

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

1794

13205

1.16

7.24

2.7

2.5

e6/l

6.1

4.4

5.65

1600

11409

(3018095) Leukocytes [#/volume] in Urine

2854

21716

1.14

7.17

3.9

3.5

e6/l

85.3

119.3

1.54

2135

15524

(3003327) Ova and parasites identified in Stool by Light microscopy

107

1517

0.58

7.12

1.5

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

560

0.33

7.07

1.0

ng/l

612.6

705.1

0.62

354

(3017143) Hepatitis C virus Ab [Presence] in Serum

583

3860

1.28

6.97

1.4

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

331

3714

0.73

6.92

2.7

2.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.71

6.67

1.2

1.3

—

(40765096) Chromosome analysis panel by Banding

2.95

6.67

1.2

1.0

—

(3022621) pH of Urine by Test strip

397

4310

0.76

6.61

2.6

3.1

—

(1002224) Polysomnography panel

110

1508

0.60

6.45

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

136

2.46

6.33

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

239

1412

1.42

6.15

1.8

1.9

mg/l

11.7

0.01

222

1291

(44816559) Phosphatidylethanol [Mass/volume] in Blood

846

0.49

6.10

1.1

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

122

1605

0.63

6.03

1.4

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

172

2.24

5.93

3.3

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

404

1.78

5.88

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.67

5.81

2.4

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

215

1273

1.42

5.51

1.9

2.3

umol/l

34.7

33.3

0.35

169

1067

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

109

1438

0.63

5.50

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

145

1795

0.67

5.42

1.6

1.5

e6/l

30809.2

13852.0

0.94

107

1293

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5639

45057

1.11

5.39

14.7

5.4

u/l

89.5

77.0

51.52

5523

41423

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

282

1.90

5.39

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

282

1.90

5.39

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

228

1370

1.40

5.38

3.1

2.7

mg/l

1.5

1.8

6.34

214

1196

(4146454)

895

0.54

5.35

2.3

2.7

—

(3019977) pH of Arterial blood

423

1.72

5.33

2.3

7.4

0.38

156

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

706

0.48

5.32

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1282

0.61

5.30

2.2

1.4

nmol/l

1.1

0.8

1.11

1048

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

12.52

5.30

1.1

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.66

5.23

1.3

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1655

12377

1.14

5.21

1.6

1.7

mg/l

2.0

1.3

4.33

1383

9595

(3036603) Volume of Urine

371

1.76

5.17

1.3

1.4

2027.6

1987.2

0.08

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1298

0.63

5.06

1.9

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1504

11209

1.14

4.98

5.5

4.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

111

587

1.58

4.95

2.7

2.8

—

(4024509)

664

0.49

4.93

1.5

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

3.79

4.91

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

763

5407

1.19

4.86

3.2

3.1

kpa

4.4

0.10

729

5199

(3009445) Proteinase 3 Ab [Units/volume] in Serum

434

2905

1.26

4.83

1.3

1.5

u/ml

17.7

17.5

—

(3004451) EKG impression Narrative

356

1.74

4.75

1.5

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

145

2.19

4.74

3.4

2.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.92

4.67

1.2

1.0

—

(40768797) Stomach Pathology biopsy report

851

8205

0.85

4.65

1.4

1.2

—

(3000330) Specific gravity of Urine by Test strip

342

3602

0.78

4.59

3.8

3.5

—

(3037522) Nuclear Ab [Titer] in Serum

733

7145

0.84

4.58

1.3

titre

534.3

536.4

0.01

187

1622

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

167

1946

0.71

4.54

2.3

ug/min

132.4

112.6

0.27

1134

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

302

1.77

4.42

1.2

u/l

29.9

22.0

0.63

256

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

702

0.53

4.38

1.4

1.5

21.6

27.6

0.74

451

(3000034) Microalbumin [Mass/volume] in Urine

702

0.53

4.38

2.4

3.0

mg/l

23.9

37.7

0.95

523

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.55

4.35

1.1

pmol/l

7.3

3.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

304

0.30

4.31

1.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

971

0.61

4.27

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

387

1.66

4.26

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

302

0.30

4.26

1.0

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

146

848

1.44

4.25

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

344

2280

1.27

4.21

1.7

1.8

u/l

37.1

38.0

0.36

290

1917

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

103

558

1.55

4.21

1.2

u/l

64.4

55.9

0.50

353

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

395

1.65

4.20

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

310

1.73

4.07

1.2

u/l

101.6

87.6

0.44

268

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1827

16593

0.90

3.99

2.2

2.3

mg/l

3.3

3.0

5.70

1560

13932

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.11

3.96

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.11

3.96

1.3

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.11

3.96

1.3

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

124

1482

0.69

3.96

1.2

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

2.96

3.89

2.1

1.9

e6/l

9434.0

127.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

573

5616

0.84

3.85

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

733

7031

0.86

3.77

2.2

2.5

ug/l

6.0

7.6

1.33

638

6020

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1078

0.65

3.71

1.1

1.2

u/l

42.4

27.0

0.75

923

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

214

1.84

3.70

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

333

1.66

3.66

1.7

1.5

u/l

5.2

6.7

0.30

141

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

504

4963

0.84

3.59

1.8

1.7

1.8

1.6

4.40

403

4124

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

426

2950

1.21

3.55

6.0

4.9

1.9

1.6

3.25

393

2787

(3025577) Chromium [Mass/volume] in Blood

559

0.54

3.53

1.6

2.0

ug/l

2.0

2.2

0.18

463

(3005719) IgG [Mass/volume] in Serum or Plasma

504

3550

1.19

3.51

2.2

g/l

10.0

10.9

5.39

461

3216

(3007853) Bacteria identified in Skin by Aerobe culture

939

6952

1.14

3.44

1.7

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

164

0.25

3.40

3.8

7.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.56

3.39

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

188

0.31

3.35

9.3

7.7

—

(3049717) Cytology report of Urine Cyto stain

350

2399

1.22

3.26

3.0

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

835

0.64

3.24

1.1

iu/ml

8.1

555.8

1.02

154

(3007930) Methemoglobin/Hemoglobin.total in Blood

416

2912

1.20

3.14

6.1

4.9

0.9

0.70

384

2746

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.78

3.13

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.49

3.12

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.13

3.03

2.6

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

151

0.28

2.99

1.6

1.5

ug/l

11.8

9.3

—

151

(3022145) Colonoscopy Study observation

607

5795

0.86

2.98

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

5.84

2.93

2.0

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

483

0.55

2.92

1.1

u/ml

3.6

4.4

—

152

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

238

1.69

2.91

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

596

0.60

2.86

1.1

1.2

mmol/l

8.4

7.8

0.38

401

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

186

1979

0.78

2.85

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

388

2727

1.19

2.83

3.7

2.9

pmol/l

4.3

4.4

1.46

351

2349

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.52

2.80

1.1

—

(3021788) Differential panel - Synovial fluid

117

1323

0.73

2.79

1.3

1.4

—

(3037756) Immunofixation for Serum or Plasma

212

1401

1.27

2.79

1.5

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

402

2841

1.19

2.77

1.8

1.4

g/l

1.6

1.2

1.74

366

2538

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.56

2.70

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

182

0.37

2.69

3.4

6.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

271

0.43

2.67

2.1

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

372

0.51

2.66

1.2

1.3

nmol/l

1.4

1.2

0.23

278

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

774

0.67

2.62

1.9

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.60

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

426

1.47

2.60

1.2

1.1

mmol/l

36.5

34.8

0.29

350

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.28

2.57

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

700

0.65

2.56

1.5

1.3

e6/l

324986.8

176644.4

0.35

478

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

164

0.36

2.56

1.0

1.1

miu/ml

1975.4

1796.2

—

164

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

129

808

1.34

2.56

5.5

6.5

mg/l

12.1

12.3

0.12

119

726

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.78

2.53

1.1

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

408

0.55

2.52

1.9

1.8

—

70.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.56

2.50

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

183

1915

0.79

2.49

1.8

1.6

—

(3017569) Oxygen content in Arterial blood

376

1.49

2.48

2.4

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

135

1466

0.76

2.47

2.1

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

105

641

1.37

2.47

1.2

1.4

u/ml

142.4

120.6

0.31

133

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

146

0.34

2.43

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2422

21304

0.93

2.43

2.3

2.2

u/l

147.2

235.8

11.95

2294

19820

(3042111) Morphology [Interpretation] in Bone marrow Narrative

131

830

1.32

2.42

1.3

—

(3033799) Differential panel - Peritoneal fluid

138

1.82

2.39

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.09

2.35

1.7

1.5

umol/l

45.1

46.6

0.09

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.18

2.34

1.6

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

118

743

1.33

2.29

1.2

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

580

0.65

2.27

1.7

2.2

u/field

3.2

1.8

0.56

214

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.38

2.23

1.0

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

783

5901

1.12

2.22

2.2

2.1

e9/l

71.6

67.7

1.88

525

4513

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

225

1.60

2.20

2.0

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

225

1.60

2.20

2.0

2.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.13

2.19

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

605

0.66

2.19

1.1

—

(3000012) Reticulocyte production index

389

0.58

2.17

1.7

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

163

1696

0.80

2.15

1.8

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

272

1906

1.20

2.14

2.2

1.5

g/l

0.0

0.50

241

1705

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

267

1869

1.20

2.13

2.2

1.5

g/l

0.0

0.00

241

1698

(3044941) Cell count panel - Synovial fluid

104

1141

0.76

2.11

1.3

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

127

1356

0.78

2.10

1.2

1.3

mg/l

752.7

551.3

0.46

120

1272

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

150

0.39

2.04

1.1

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1142

8810

1.09

2.04

2.2

2.7

19.1

22.1

9.48

1016

7308

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

108

1172

0.77

2.03

1.2

1.4

e6/l

23835.2

1445.4

0.47

974

(3022217) INR in Platelet poor plasma by Coagulation assay

1170

10510

0.92

2.00

24.1

30.6

inr

1.4

1.5

1.10

156

1434

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

108

1169

0.77

2.00

1.2

1.3

e6/l

32.5

22.9

0.14

923

(3035320) C reactive protein [Mass/volume] in Body fluid

395

1.42

1.99

2.4

2.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.25

1.98

2.4

2.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

279

1.50

1.97

1.5

1.6

—

(3020650) Glucose [Presence] in Urine

132

0.38

1.91

1.3

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

118

1.77

1.89

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

485

0.65

1.88

1.1

u/ml

0.5

1.2

1.39

190

(3014133) Dog dander IgE Ab [Units/volume] in Serum

275

0.54

1.83

1.1

u/ml

12.6

2.7

—

116

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

141

0.41

1.80

1.0

1.5

ng/l

130.7

117.8

—

141

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

453

1.36

1.80

1.2

titre

314.0

163.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

453

1.36

1.80

1.2

titre

145.6

174.7

0.13

(3025468) Yersinia sp identified in Specimen by Organism specific culture

109

707

1.29

1.79

1.2

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

109

707

1.29

1.79

1.2

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

335

0.60

1.77

1.0

1.1

u/ml

1.0

2.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

116

0.36

1.76

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

109

710

1.28

1.74

1.2

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

186

1.57

1.74

34.4

27.0

ug/l

115.4

112.3

0.13

157

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

737

0.73

1.71

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

258

0.55

1.71

1.1

u/ml

0.8

2.4

—

102

(3043409) Potassium [Moles/volume] in Arterial blood

305

2206

1.16

1.70

4.5

4.3

mmol/l

3.9

0.27

282

2066

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

530

4903

0.90

1.69

4.7

2.5

ml/min/173m2

61.1

60.1

0.24

232

1975

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.92

1.68

1.0

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

313

2275

1.15

1.65

1.5

1.6

titre

100.0

289.8

—

120

(3019420) Tryptase [Mass/volume] in Serum or Plasma

200

0.50

1.63

1.5

1.6

ug/l

8.8

9.6

0.13

176

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.78

1.60

3.0

1.9

mg/l

2.2

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

150

1515

0.82

1.58

3.9

3.7

mg/l

39.9

27.7

2.45

110

1019

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

1.54

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.94

1.51

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.94

1.51

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.94

1.51

4.5

5.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.94

1.51

1.0

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

168

1669

0.84

1.50

1.3

1.4

ug/g

266.3

280.3

0.39

101

1009

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

115

1186

0.81

1.50

1.2

mmol/l

3.8

3.9

1.56

107

1103

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1038

0.79

1.50

2.9

3.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

1.50

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

215

0.54

1.50

1.1

u/ml

0.3

0.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

633

0.74

1.49

1.4

1.7

u/ml

23.1

25.5

0.15

151

(3024928) Oxygen saturation in Venous blood

201

1425

1.18

1.49

2.4

3.1

—

(3006270) Folate [Moles/volume] in Blood

632

0.74

1.47

1.2

nmol/l

296.8

322.2

0.45

493

(44813793)

318

0.63

1.47

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

369

1.36

1.47

2.1

1.8

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

167

0.50

1.40

11.6

12.0

mmol/l

0.8

0.7

—

150

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

117

1.64

1.40

1.5

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

587

0.74

1.39

1.0

1.1

au/ml

6.5

20.8

—

(3044927) Protein electrophoresis panel - Urine

839

0.78

1.36

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

124

849

1.22

1.36

7.2

16.0

mmol/l

7.7

7.5

0.27

102

699

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

268

1.40

1.35

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.98

1.34

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

427

3215

1.11

1.34

1.5

g/l

1.9

1.5

10.39

357

2721

(3028192) IgG subclass 2 [Mass/volume] in Serum

529

1.28

1.34

1.2

1.4

g/l

2.6

3.0

1.33

374

(3024522) Salmonella sp identified in Specimen by Organism specific culture

107

723

1.24

1.33

1.2

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

216

0.58

1.31

1.0

1.2

—

9.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

834

0.79

1.31

3.8

4.1

umol/l

358.9

346.5

0.32

689

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

650

1.25

1.30

1.1

g/l

1.6

1.5

1.06

568

(3034770) Mitochondria Ab [Titer] in Serum

132

1317

0.83

1.28

1.2

titre

664.3

1108.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

833

6482

1.08

1.28

4.9

3.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

405

0.70

1.28

1.1

u/ml

0.5

0.7

0.39

163

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

277

2040

1.14

1.27

2.2

1.5

g/l

0.1

0.0

0.50

246

1832

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

106

720

1.23

1.27

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

114

1.61

1.27

1.4

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

104

706

1.23

1.25

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

154

1088

1.18

1.24

1.2

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

529

1.26

1.22

1.2

1.4

g/l

6.5

6.9

0.40

373

(3024139) IgG subclass 3 [Mass/volume] in Serum

529

1.26

1.22

1.2

1.4

g/l

0.5

0.4

0.84

377

(3003888) Timothy IgE Ab [Units/volume] in Serum

410

0.71

1.21

1.0

1.1

u/ml

5.3

2.1

0.43

188

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

642

1.24

1.20

1.2

u/ml

4.9

3.6

0.25

216

(3020891) Body temperature

378

2848

1.11

1.20

5.1

4.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

122

1216

0.83

1.19

1.2

—

8.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

108

741

1.22

1.19

1.2

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

178

0.56

1.18

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

205

1958

0.87

1.18

4.5

4.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

212

2020

0.87

1.18

1.2

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.61

1.18

1.2

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

427

0.72

1.18

1.3

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

1.16

0.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

214

2029

0.88

1.12

1.2

u/ml

1.1

0.7

0.18

208

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

222

1.39

1.11

1.5

umol/l

69.0

124.7

1.43

124

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

136

0.55

1.09

1.0

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1185

9392

1.06

1.09

2.2

2.6

g/l

2.2

2.3

5.48

1116

8561

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

255

1.34

1.01

1.9

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

255

1.34

1.01

1.9

1.4

—

(4062490)

529

1.23

1.00

1.2

1.4

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.99

0.0

1.0

—

38.7

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.99

0.0

1.0

—

19.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.99

0.0

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

188

0.62

0.98

1.4

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.72

0.98

1.1

1.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.59

0.98

1.0

1.6

—

7.9

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.65

0.97

1.1

1.2

ng/l

59.2

194.4

—

(3051593) INR in Capillary blood by Coagulation assay

420

0.75

0.96

7.5

11.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

1124

0.85

0.95

1.1

—

(40768443) Skin Pathology biopsy report

264

2441

0.90

0.95

1.2

—

(3004775) Volume in Urine collected for unspecified duration

643

0.80

0.95

2.3

664.9

646.6

0.11

425

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.80

0.95

1.0

1.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

246

0.68

0.95

2.8

5.7

62.8

71.5

0.49

205

(3026008) Bacteria identified in Urine by Culture

2186

18811

0.96

0.95

3.1

3.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.27

0.94

1.0

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.85

0.94

1.6

2.2

59.8

65.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

131

1.47

0.93

1.2

1.8

g/l

13.1

14.5

0.28

100

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

287

2168

1.11

0.93

2.2

1.4

g/l

36.4

37.4

2.12

251

1805

(3016750) Collection duration of Urine

435

0.77

0.91

2.2

2.1

min

510.4

499.3

0.32

320

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

163

0.61

0.90

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

213

1588

1.12

0.88

1.5

1.6

iu/ml

50.6

4.0

0.51

372

(4027681)

204

1.35

0.87

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

533

0.80

0.86

1.3

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

101

987

0.85

0.86

1.2

u/ml

63.5

45.7

0.36

107

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

278

1.29

0.85

1.0

1.1

mg/l

361.2

299.0

0.74

251

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

587

0.81

0.85

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

301

1.28

0.83

1.0

1.1

mg/l

54.4

41.1

0.98

258

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

626

1.19

0.83

1.2

u/ml

4.2

4.4

0.09

280

(3020191) Ethanol [Moles/volume] in Serum or Plasma

426

0.78

0.80

1.3

1.2

promille

1.3

1.2

0.08

321

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

347

2670

1.09

0.79

1.2

iu/ml

137.8

122.4

0.24

965

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.79

0.0

5.1

—

390.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.79

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.55

0.79

1.3

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

138

1307

0.88

0.79

1.2

titre

168.7

157.5

0.06

107

(3027874) Urate [Moles/volume] in Urine

0.00

0.78

0.0

1.1

—

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2648

22618

0.97

0.77

3.1

3.2

ng/l

1485.2

1747.8

2.93

2402

19583

(40761539) Cells [Type] in Urine sediment by Light microscopy

137

1.40

0.77

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

113

818

1.15

0.76

1.2

1.6

g/l

0.7

0.9

0.60

621

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

106

765

1.16

0.75

1.2

1.3

nmol/l

0.7

4.1

0.98

100

733

(3017732) Neutrophils [#/volume] in Blood

426

3803

0.93

0.75

3.9

3.1

e9/l

5.2

4.1

6.59

325

2665

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

402

0.79

0.74

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

851

6772

1.05

0.73

3.0

3.2

ng/l

230.5

253.7

0.81

794

6222

(3013166) Neutrophils/100 leukocytes in Synovial fluid

232

0.72

0.73

1.6

1.3

69.7

58.5

0.81

201

(3026250) Tacrolimus [Mass/volume] in Blood

153

1.36

0.73

31.0

33.6

ug/l

7.2

7.3

0.01

138

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

106

768

1.15

0.72

1.2

1.3

nmol/l

0.1

0.3

—

(40762814) Titanium [Mass/volume] in Blood

163

0.66

0.72

2.0

2.2

ug/l

7.4

3.4

—

(3019225) pH of Specimen

824

6558

1.05

0.71

5.5

3.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.56

0.70

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

156

1451

0.89

0.69

1.3

1.2

u/ml

28.6

44.7

0.50

(3041354) Potassium [Moles/volume] in Venous blood

133

983

1.13

0.69

3.0

2.3

mmol/l

4.1

0.13

133

974

(3035285) Chloride [Moles/volume] in Venous blood

133

983

1.13

0.69

3.0

2.3

mmol/l

104.1

105.9

3.57

133

973

(40768446) Kidney Pathology biopsy report

185

1.31

0.66

1.2

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.62

0.66

3.7

3.2

—

(4211845)

349

0.79

0.66

3.7

3.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

246

0.75

0.66

1.1

1.2

ratio

1.1

—

(3023410) Appearance of Cerebral spinal fluid

465

1.18

0.65

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

333

2586

1.08

0.65

2.1

1.4

g/l

10.5

10.4

0.22

277

2136

(3026389) Candida sp identified in Specimen by Organism specific culture

736

0.86

0.63

1.2

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

215

1642

1.09

0.63

2.5

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

148

0.68

0.63

1.3

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1267

10218

1.04

0.63

2.2

2.6

umol/l

10.2

12.5

23.65

1194

9303

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.58

0.62

1.5

2.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.58

0.62

1.5

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.58

0.62

1.7

2.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

360

1.21

0.62

1.2

1.3

u/ml

0.3

1.2

1.37

193

(3016650) Hepatitis A virus Ab [Presence] in Serum

654

1.15

0.62

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

186

0.72

0.62

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

186

0.72

0.62

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

186

0.72

0.62

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

186

0.72

0.62

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

157

0.69

0.61

1.8

2.8

mmol/l

6.1

8.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

299

0.78

0.61

1.3

1.7

—

6.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

252

0.76

0.61

1.0

1.2

—

(4133840)

115

1.38

0.61

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

130

969

1.12

0.61

3.0

2.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

0.0

—

(3006462) Nitrate [Presence] in Urine

317

0.79

0.61

3.0

3.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

137

0.67

0.61

1.3

1.5

178.5

192.8

0.31

128

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

7.0

—

0.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

408

0.82

0.60

1.2

mmol/l

12.1

11.7

0.09

117

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

296

2298

1.08

0.60

2.2

1.5

g/l

1.1

0.5

1.67

250

1927

(3030981) Hyaline casts [#/volume] in Urine by Automated count

405

3583

0.94

0.59

2.9

2.6

e6/l

0.3

0.21

399

3509

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

102

1.39

0.58

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.53

0.58

1.0

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

147

1352

0.91

0.56

1.3

1.2

u/ml

3.5

7.2

0.63

141

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

236

1.24

0.55

2.6

2.0

u/ml

977.4

861.1

0.18

230

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

149

1367

0.91

0.55

1.3

1.2

u/ml

9.3

5.1

0.83

218

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.50

0.54

4.9

4.8

ug/min

76.9

48.0

0.40

(3003740) Influenza virus B Ag [Presence] in Specimen

359

1.19

0.54

1.1

—

(3020491) Glucose [Moles/volume] in Blood

465

0.84

0.53

2.2

mmol/l

6.9

7.1

0.21

315

(3004588) Protein electrophoresis panel - Serum or Plasma

561

4899

0.95

0.53

2.1

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

125

1152

0.90

0.52

1.2

u/ml

8.2

7.1

0.06

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

179

0.74

0.51

1.0

—

(4212803)

1.39

0.50

1.1

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

326

0.82

0.50

1.3

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.66

0.49

1.1

1.4

—

(40757373) Influenza virus identified in Isolate

135

1.30

0.49

1.7

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

233

0.79

0.48

1.3

nmol/l

0.2

0.38

173

(3025941) Bacteria identified in Stool by Culture

317

2801

0.94

0.48

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

143

1.28

0.48

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

203

1.23

0.48

1.4

1.9

nmol/l

17.3

4.8

0.42

170

(3047007) Chlamydophila sp Ab [Presence] in Serum

557

0.87

0.47

1.2

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

249

1.21

0.47

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

249

1.21

0.47

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

873

0.90

0.46

3.0

2.3

mg/l

28.2

27.9

0.01

216

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.67

0.46

2.3

2.7

u/field

0.1

0.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.39

0.46

1.8

1.5

—

(4198724)

1.39

0.46

1.5

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.59

0.46

1.0

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

593

1.13

0.45

1.1

1.2

121.0

114.4

0.99

528

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

197

1.23

0.45

2.4

2.0

ug/l

38.3

53.1

1.93

192

(3044007) Cell count panel - Peritoneal fluid

130

1.28

0.44

2.8

2.4

—

(3028707) Methadone [Presence] in Urine by Screen method

213

1.21

0.44

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

563

4886

0.96

0.44

2.9

3.9

ng/l

83.0

98.9

5.03

485

4089

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

614

0.88

0.43

1.1

1.2

miu/ml

138.8

220.2

1.30

210

(3002523) Influenza virus A Ag [Presence] in Specimen

360

1.16

0.43

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

355

0.84

0.42

1.6

2.0

u/field

2.0

2.4

0.19

241

(3011648) Oxygen content in Venous blood

471

1.13

0.42

1.3

2.1

10.7

11.1

0.27

471

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.41

0.0

4.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.4

—

2.2

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.41

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.41

0.0

9.1

—

44.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

116

0.72

0.41

1.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

124

1126

0.92

0.41

1.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

209

0.80

0.41

1.2

1.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.1

—

2.7

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.40

0.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

153

0.76

0.40

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

520

1.12

0.40

1.2

1.3

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.39

0.0

1.0

—

14029.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

1.30

0.38

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

133

1.25

0.38

3.1

4.8

—

(40758292) HTLV I+II Ab panel - Serum

1.39

0.38

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.39

0.38

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

222

1744

1.06

0.38

3.0

3.1

nmol/l

0.8

0.08

173

1353

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

279

1.17

0.38

1.1

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.31

0.37

2.6

2.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

366

1.14

0.37

1.1

—

(3024471) HLA-A [Type]

119

1.26

0.36

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

157

1.22

0.36

2.0

1.8

—

(3001729) Color of Synovial fluid

1.27

0.36

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

178

1582

0.94

0.36

1.5

g/l

1.1

1.2

0.95

166

1489

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.39

0.36

2.2

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

375

0.87

0.36

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

367

1.14

0.35

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

367

1.14

0.35

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

102

0.74

0.35

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

213

0.82

0.35

1.3

umol/l

15.0

10.4

0.15

144

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

274

1.16

0.34

2.1

2.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

121

0.76

0.34

1.0

1.1

97.5

85.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

382

0.87

0.34

1.1

—

(3034426) Prothrombin time (PT)

151

1.22

0.33

1.1

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

0.68

0.33

1.2

1.3

mu/l

292.8

690.9

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

0.68

0.33

1.2

1.3

79.3

71.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

148

0.79

0.33

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

148

0.79

0.33

1.0

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

495

0.89

0.33

1.2

u/ml

51.6

73.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.13

0.32

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.13

0.32

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

442

0.89

0.32

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

268

1.15

0.32

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

253

1.15

0.31

1.7

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

371

1.12

0.31

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

227

0.84

0.30

2.5

2.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

684

1.09

0.30

1.1

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

636

1.09

0.30

1.1

1.2

u/ml

309.4

290.4

0.26

398

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

118

0.78

0.29

1.0

1.1

94.0

84.7

—

(44806420)

253

0.86

0.29

2.6

2.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

217

0.85

0.29

3.1

2.7

umol/l

31.2

29.0

0.50

164

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

279

1.14

0.29

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

498

0.90

0.28

1.2

u/ml

21.3

41.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

139

1.20

0.28

2.4

e6/l

6661.6

24996.5

0.65

(3024932) HLA-DR beta [Type]

116

1.22

0.28

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

732

0.92

0.28

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1621

13309

1.02

0.28

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

178

1.17

0.28

10.9

15.9

nmol/l

1730.7

1351.0

0.67

173

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

100

0.75

0.27

1.0

—

(3011985) Renin [Units/volume] in Plasma

100

777

1.07

0.27

1.4

1.3

mu/l

118.5

61.0

0.86

686

(3023487) Leukocytes [#/volume] in Peritoneal fluid

163

1.18

0.27

2.2

2.7

e6/l

571.1

864.7

0.41

121

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

171

1.17

0.26

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

118

1048

0.94

0.26

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

125

0.80

0.26

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.69

0.26

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.69

0.26

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.69

0.26

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.69

0.26

1.6

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

161

0.83

0.26

2.7

2.9

mu/l

10.3

22.3

2.31

150

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

250

1.13

0.26

1.7

1.4

u/l

19.9

1550.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.66

0.26

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

282

1.12

0.25

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

290

1.12

0.25

1.3

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.23

0.25

1.0

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

267

0.87

0.25

1.2

4.4

mg/l

61.4

83.4

0.86

176

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.27

0.25

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.72

0.24

1.2

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

157

1245

1.05

0.24

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

177

1546

0.95

0.24

1.4

1.5

g/l

0.2

0.27

165

1461

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

466

0.91

0.24

1.2

u/ml

2.4

4.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

510

4365

0.97

0.23

3.6

3.3

g/l

122.5

130.1

11.87

500

4249

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

391

3360

0.97

0.23

4.6

4.0

48.4

47.0

0.51

391

3312

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.30

0.23

1.2

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.30

0.23

1.8

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

508

0.92

0.23

1.2

u/ml

1.4

58.5

—

(3024263) Appearance of Synovial fluid

360

0.90

0.22

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

381

1.09

0.22

2.4

2.2

ug/min

86.2

190.3

—

102

(42529406) Shigella sp [Presence] in Stool by Culture

184

1601

0.96

0.22

1.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

680

1.07

0.22

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1155.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

1.9

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.77

0.21

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

566

0.93

0.21

1.1

iu/ml

2.5

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.76

0.21

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

271

1.11

0.20

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

318

2573

1.03

0.20

2.2

1.4

g/l

3.4

3.1

9.02

261

1978

(3043410) Blood group antigens tested for on Red Blood Cells

160

1.15

0.20

1.8

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.20

0.0

9.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.20

0.0

1.8

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

168

1.14

0.20

8.5

11.0

nmol/l

919.4

788.3

0.49

157

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

244

0.89

0.20

1.0

1.1

iu/ml

6.4

14.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.78

0.20

6.4

12.3

mmol/l

5.7

5.1

—

(3037121) Protein [Mass/volume] in Urine

238

2054

0.97

0.20

2.5

g/l

0.3

0.07

124

738

(3014765) Yersinia sp identified in Stool by Organism specific culture

184

1594

0.96

0.19

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

537

0.93

0.19

1.2

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

425

0.92

0.19

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

458

1.07

0.18

2.8

3.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

137

0.85

0.18

1.4

2.2

ug/l

1.1

0.9

0.35

125

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

329

0.91

0.18

1.1

1.4

u/l

12.0

6.3

0.61

266

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

183

1583

0.96

0.18

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

128

1116

0.96

0.18

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

372

0.92

0.18

2.3

2.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

207

0.89

0.18

1.2

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

354

2879

1.03

0.17

1.2

1.3

u/ml

255.4

250.7

0.04

322

2660

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

774

0.95

0.17

1.1

—

(3025315) Body weight

0.76

0.17

4.2

5.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.74

0.17

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.72

0.17

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.79

0.15

14.5

11.0

—

(3025130) Human papilloma virus identified in Specimen

300

0.92

0.15

1.4

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

343

0.92

0.15

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

140

1.13

0.15

1.1

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

170

1372

1.03

0.14

1.8

1.5

—

(40761536) Microorganisms panel - Urine sediment

578

4741

1.02

0.14

4.0

4.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

203

0.90

0.14

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method

262

1.08

0.13

1.8

2.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.82

0.13

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

245

0.92

0.13

1.1

—

(3012565) Volume of 24 hour Urine

296

1.07

0.12

2.0

1599.8

1925.4

1.05

250

(3048879) Bone marrow aspiration report

151

1.10

0.11

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.16

0.11

1.7

1.6

—

(3027944) Amphetamines [Presence] in Urine

406

0.94

0.11

1.6

1.5

—

(3017704) Immunofixation for Urine

388

0.95

0.11

1.6

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

363

1.06

0.11

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

217

0.92

0.11

1.2

1.1

iu/ml

165.8

227.7

0.51

212

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

0.91

0.10

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.13

0.10

1.2

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

173

0.92

0.09

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

431

3642

0.99

0.09

3.8

3.3

mmol/l

25.9

25.2

4.26

422

3528

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.04

0.09

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.04

0.08

1.0

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.02

0.08

1.2

1.0

—

2.5

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.79

0.08

1.4

1.0

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.77

0.08

1.4

1.0

mmol/l

—

(3028300) Cannabinoids [Presence] in Urine

418

0.96

0.08

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

671

1.03

0.08

1.2

1.3

nmol/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

2756

1.01

0.08

2.1

1.4

g/l

4.1

3.9

1.23

257

1937

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

214

0.93

0.08

1.1

u/l

1.0

1.1

0.42

(3015183) Erythrocyte sedimentation rate

138

1.09

0.08

1.3

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.06

0.08

1.3

1.1

—

(44806071)

1.04

0.08

1.3

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

2765

1.01

0.08

2.1

1.4

g/l

8.1

7.5

6.08

262

2004

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

154

0.92

0.08

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.81

0.07

9.8

4.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

409

3449

0.99

0.07

1.9

2.1

nmol/l

9.6

14.7

26.94

337

2938

(21494890) Protein electrophoresis panel - 24 hour Urine

653

0.97

0.07

1.7

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.87

0.07

1.7

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

602

0.97

0.07

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

1.08

0.07

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.86

0.06

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.86

0.06

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.84

0.06

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

2762

1.01

0.06

2.1

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

253

0.96

0.05

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

202

0.95

0.05

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

894

1.02

0.04

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

714

0.98

0.04

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

319

0.97

0.04

1.6

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

272

2249

1.01

0.04

2.6

1.6

mg/l

42.2

38.9

0.22

208

1802

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

226

0.96

0.04

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.08

0.03

1.3

1.1

—

(3016879) Cocaine [Presence] in Urine

393

0.98

0.03

1.6

—

(4306422)

616

1.02

0.02

1.2

—

(21494434) Karyotype in Bone marrow

475

1.02

0.02

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

734

0.99

0.02

1.2

1.3

pmol/l

261.3

262.6

0.02

540

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

152

1.04

0.02

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

257

0.97

0.02

1.1

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.94

0.01

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

415

0.98

0.01

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

627

1.01

0.01

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

139

0.96

0.01

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

189

0.97

0.01

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.95

0.01

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

130

0.96

0.00

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

271

2254

1.00

0.00

2.6

1.6

mg/l

49.3

49.9

0.06

204

1810

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

262

2180

1.00

0.00

2.6

1.5

ratio

4.0

2.3

0.36

180

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.97

0.00

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

150

1.00

0.00

1.1

—

(3045716) Anion gap in Serum or Plasma

364

1.01

0.00

2.3

2.1

mmol/l

7.9

9.1

1.43

266

(3009871) Measles virus Ab [Titer] in Serum

114

1.02

0.00

1.5

1.7

—

(4268621)

420

0.99

0.00

2.1

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

413

0.99

0.00

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

121

0.96

0.00

1.5

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.6

—

0.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

3.9

—

18.1

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

121.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1541.4

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.91

0.00

1.0

1.1

—

12.6

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.97

0.00

1.4

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.97

0.00

1.0

1.2

—

31.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.99

0.00

1.0

1.1

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

20.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.85

0.00

1.2

1.1

u/l

17.0

9.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.97

0.00

1.4

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.93

0.00

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.91

0.00

1.0

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.00

0.00

1.2

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.95

0.00

1.2

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BRONCHUS_LUNG_EXALLC – Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

GWS hits: 9

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers) (C3_BRONCHUS_LUNG_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints